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ABSTRACT 
Natural antimicrobials, from plant, animal or microbial sources, have good potential 
for use as preservative systems to improve food safety, extend shelf life and enhance the 
overall quality of food products, while promoting the image of “healthier” foods.  The overall 
objective of this research was to evaluate the antimicrobial efficacy of phosvitin alone or 
combined with carvacrol or nisin against four human enteric foodborne pathogens.  Growth 
inhibition of Salmonella enterica, Listeria monocytogenes, Escherichia coli O157:H7 or 
Staphylococcus aureus by the antimicrobials used singly or in combination in brain heart 
infusion (BHI) broth (35 °C, 24 hours) was evaluated using a Bioscreen C turbidometer (OD 
600nm).  Subsequently, selected concentrations of the antimicrobials were evaluated for their 
effectiveness in controlling growth of the pathogens and background microflora in onion 
mushroom soup at 12 ºC and 35 ºC.  Additional experiments involving UV spectroscopy and 
transmission electron microscopy (TEM) were performed to investigate the antibacterial 
mechanism of action of carvacrol in E. coli O157:H7 and L. monocytogenes Scott A. In BHI 
broth the minimum inhibitory concentration (MIC) of phosvitin and carvacrol was 80 mg/ml 
and 0.14 mg/ml, respectively, for both S. enterica and L. monocytogenes.  The MIC of 
phosvitin and carvacrol was greater than 100 mg/ml and 0.12 mg/ml, respectively (for S. 
aureus) and 80 mg/ml and 0.12 mg/ml, respectively, for E. coli.  In onion mushroom soup, 
the combination of phosvitin (60 mg/ml) and carvacrol (0.40 mg/ml) exerted the greatest 
cidal effect throughout storage against all foodborne pathogens tested.  Irrespective of 
storage temperature (12 °C or 35 °C), phosvitin combined with nisin did not offer enhanced 
antibacterial effect above that provided by phosvitin used alone.  For all organisms, leakage 
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of A260 absorbing material from the bacterial cells increased significantly with increased 
carvacrol concentration and exposure time.  There was a very strong correlation between the 
initial rate of release of A260 material and death rate of the pathogens (r = 0.998).  At 0.4 
mg/ml carvacrol, E. coli O157:H7 cells appeared collapsed and showed signs of lysis when 
observed by TEM.  At 0.4 and 0.6 mg/ml carvacrol, L. monocytogenes cells showed no 
apparent physical damage (distortion of cell shape) despite substantial loss of viability; 
however, exudation of intracellular material was detected by UV spectroscopy and TEM 
photographs of negatively stained cells. 
Based on results of the present studies it is concluded that: i) use of phosvitin and 
carvacrol in combination has good potential for controlling growth of foodborne pathogenic 
bacteria in onion mushroom soup and ensuring the microbial safety of this potentially 
hazardous food product, ii) phosvitin/nisin combinations are far less effective for inhibiting 
growth of pathogens in soup, iii) death of bacterial cells exposed to carvacrol involves 
damage to the cytoplasmic membrane. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Bacterial pathogens present in food and beverages can infect humans and cause 
foodborne illnesses.  The World Health Organization estimates that 1.8 million people died 
in the world in 2005 due to foodborne related illnesses.  The Center for Disease Control and 
Prevention estimated that foodborne diseases causes approximately 76 million illnesses, 
325,000 hospitalizations and 5000 deaths in the United States each year (Mead et al., 1999).  
Based on recent epidemiological data, there has been a decrease in the incidence of 
foodborne disease (9.4 illnesses), hospitilizations (55,961) and deaths (1,351) annually 
(Scallan et al., 2011).  The US cost of foodborne illness associated with Campylobacter 
jejuni, Clostridium perfringens, Escherichia coli O157:H7, Listeria monocytogenes, 
Salmonella, Staphylococcus aureus and Toxoplasma gondii is between $6.5 and $34.9 billion 
(Buzby and Roberts, 1997).  Total elimination of bacterial pathogens is virtually impossible 
so government, food manufacturers, processors and retailers try to ensure that foodborne 
diseases are minimized for consumers. 
The increased usage of foods formulated with chemical preservatives has raised 
consumer health concerns and created a demand for more “natural” and minimally processed 
foods.  As a result, there has been a great interest in naturally produced antimicrobial agents 
to replace chemically synthetic preservatives such as nitrites, benzoates, sulphites, sorbates, 
salt and ethyelenediaminetetraacetic acid.  The insistence for more natural antimicrobials has 
driven the trend towards “Green Consumerism”.  “Green” antimicrobials should possess the 
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following attributes: 1) low mammalian toxicity/cytotoxicity, 2) low skin sensitization 
potential, 3) low eco-toxicity, 4) low bioaccumulation potential, 5) low emission potential 
during manufacture, application or post application, 6) no or low volatile organic compound 
(VOC) content, as applicable, and 7) complete effectiveness against the relevant target 
organisms (Sofos, 1998; Kruger and Mann, 2003; Shrankel, 2004; Davidson et al., 2005; 
Smith, et al., 2005; Rulis, 2009).  Natural antimicrobials have good potential for use as 
preservative systems to improve food safety, extend shelf life and improve the overall quality 
of food products, while promoting the image of “healthier” foods.  In order for the food 
industry to fully make the change from the use of synthetic sources to purely natural sources 
research must address, the limits of antimicrobial activity, the overall cost, the most effective 
concentration, optimization of the antimicrobial, use of hurdle technology and address 
regulatory concerns. 
The food industry is addressing the issue by gradually incorporating natural 
antimicrobials from, plant, animal or microbial sources into food products to replace the 
more traditionally used synthetic chemical preservatives.  Poultry eggs contain many proteins 
that have antimicrobial functions and phosvitin, a major egg yolk protein, is a highly 
phosphorylated protein that has the ability to bond with metal cations (Khan et al., 2000).  
The ablility to bind metal cations deprives the environment of essential nutrients and possibly 
interacts with the membranes of foodborne pathogens.  It is this property which could 
theoretically make it a candidate for uses as a natural antimicrobial.  Carvacrol, an essential 
oil from oregano and thyme, is a phenolic compound that has been shown to have 
antimicrobial activity.  It is believed to exert antimicrobial activity by disrupting the 
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cytoplasmic membrane of foodborne pathogens. In some instances the high concentration 
needed for it to be effective as an antimicrobial would not be organoleptically pleasing to 
consumers.  Therefore, efforts need to be made to use plant essential oil such as carvacrol in 
very low amounts that would be effective in controlling microorganisms while not 
contributing an overwhelming flavor and/or odor notes to food products.  One approach to 
achieve this type of application is by combining low levels of the essential oil with an 
antimicrobial to get the desired result.  Nisin, produced by Lactococcus lactis spp lactis, is 
the only approved bacteriocin used in food.  It is primarily active against Gram-positive 
bacteria by causing pores in the cell membrane, resulting in leakage of cytoplasmic 
constituents.  Generally, food applications of nisin can be expensive based on the quantities 
needed for antimicrobial efficacy.  In addition, nisin has little or no effect on Gram-negative 
bacteria except in instance when a membrane destabilizing agent such as EDTA is used in 
combination with this bacteriocin.  It is hypothesized that the antimicrobial efficacy of nisin 
against Gram-negative bacteria is enhanced when this bacteriocin is combined with 
phosvitin. 
 Properties of these three sources of natural antimicrobials can be used to improve 
microbial safety of foods.  Combining these natural antimicrobials could possibly increase 
the effectiveness of the antimicrobials proving to be better than if they were used alone 
against foodborne pathogens.  Synergistic or additive effects between the antimicrobials may 
permit the use of relatively low amounts of each antimicrobial and thereby reduce cost of the 
antimicrobial treatment while improving the antimicrobial efficiency.  
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The first objective was to evaluate and establish the minimum inhibitory 
concentration (MIC) of selected antimicrobials in laboratory broth medium against various 
foodborne pathogens.  The second objective was to determine the antimicrobial efficacy of 
phosvitin, carvacrol and nisin alone or phosvitin/carvacrol combination or phosvitin/nisin 
combination against the various human enteric pathogens Escherichia coli O157:H7, 
Salmonella enterica, Listeria monocytogenes, and Staphylococcus aureus in a food product. 
After determining the antimicrobial efficacy it was important to establish the possible 
mechanism of action of carvacrol correlated to death and the effect of this natural 
antimicrobial on the extent of sub-lethal injury in populations of foodborne human enteric 
pathogens that survive exposure to carvacrol. 
 
Dissertation Organization 
This dissertation is organized into seven chapters.  The first chapter is a general 
introduction.  The second chapter is a general literature review that contains information 
relevant to the research performed (Chapters 3-6) followed by a general conclusion.  The 
seventh and final chapter provides a general summary of the research described.  All 
pertinent tables, figures and graphs appear at the end their respective paper, which follows a 
specified journal format.  References can be found at the conclusion of each chapter with 
formatting following journal specifications.  It is the intent that Chapter 3 be submitted to the 
Journal of Food Protection, Chapter 4 Journal of Food Science, Chapter 5 International 
Journal of Food Microbiolgy, and Chapter 6 Journal of Food Protection.  The following 
papers entitled “Antimicrobial efficacy of phosvitin alone or combined with nisin against 
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Listeria monocytogenes in a laboratory broth medium at 35 °C” and “Control of Salmonella 
enterica and Staphylococcus aureus in a laboratory medium and a commercial-type soup 
using phosvitin, carvacrol, or combinations” were presented at the annual meeting of the 
International Association of Food Protection in Anaheim, CA (August 2010), and Madison, 
WI (2011), respectively.  Lastly, paper entitled “Antimicrobial efficacy of phosvitin, nisin, 
and combinations against Salmonella enterica in a laboratory medium and a commercial-type 
soup” will be presented at the annual meeting of the Institute of Food Technologists in New 
Orleans, LA (June 2011). 
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CHAPTER 2. LITERATURE REVIEW 
 
Phosvitin 
Composition  
Phosvitin is a phosphoglycoprotein that was first isolated in 1949 by Mecham and 
Olcott.  It is made from vitellogenin (produced in the liver) and is found exclusively in the 
granule fraction of chicken egg yolk (Wallace and Morgan, 1986) in which it represents 4% 
of egg yolk dry matter.  Phosvitin has a molecular weight of 35 kDa and contains 10% 
phosphorus (80% of total yolk phosphorus), 12.3% nitrogen, and 6.5% carbohydrate 
(Renugopalakrishnan, 1985; Burley and Vadhera, 1989; Xu et al., 2007).  It is the major 
protein component in egg yolk and is currently known as the most phosphorylated protein in 
nature.  Phosvitin has an amino acid sequence containing 217 amino acids of which 123 are 
serines, with 90% of them being phosphorylated (Fig. 1; Taborsky, 1983; Byrne et al., 1984; 
Clark, 1985).  This distinct, polyanionic, highly phosphorylated protein, contains 56% serine 
residues, 15% basic and 10% acidic amino acid residues (Taborsky, 1963; Taborsky and 
Mok, 1967; Byrne et al., 1984; Losso, 1994; Xu et al., 2007).  Its unique amino acid 
sequence leads to the structure and properties of phosvitin. 
 
Figure 1. Amino acid sequence of hen egg yolk phosvitin. Adapted from Byrne et al. 1984; 
Clark 1985). 
 
 
 
 
A E F G T E P D A K T S S S S S S A S S T A T S S S S S S A S S P N R K K P M D E E E N D Q V K Q 
A R N K D A S S S S R S S K S S N S S K R S S S K S S N S S K R S S S S S S S S S S S S R S S S S S S S 
S S S N S K S S S S S S K S S S S S S R S R S S S K S S S S S S S S S S S S S S K S S S S R S S S S S S K 
S S S H H S H S H H S G H L N G S S S SS S S S R S V S H  H S H E H H S G H L E D D S S S S S S S S 
V L S K I W G R H E I Y Q   
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Extraction and isolation/purification 
Phosvitin was first isolated in 1949 by Mecham and Olcott and the methods described 
by those researchers are most commonly used for extraction and isolation.  Sigma Chemical 
Co. uses another method described by Sundararajanet al., 1960 for extraction and isolation of 
phosvitin.  The current issue with previously used methods for preparation, extraction and 
isolation (size-exclusion, anion-exchange chromatography, hydrophobic-interaction 
chromatography, gel electrophoresis) is that chemicals used are not food-grade or non-
aqueous (Wallace and Morgan, 1986; Castellani et al., 2003) limiting use of the methods for 
production of foodgrade phosvitin.  Choi et al., (2005) were able to successfully purify egg 
yolks by a sodium chloride method.  Tedious extraction and purification methods for 
phosvitin are largely responsible for the relatively high cost of this glycoprotein.   The cost of 
phosvitin is $1130.00 per gram based on current price listed in the Sigma 2011 catalog.  
More recently, researchers at Iowa State University developed a water/ethanol-based method 
that permits an efficient cost-effective way of extracting and purifying phosvitin from yolks 
of hens’ eggs.  Varying yield of final product, purity and polypeptide composition (Table 1; 
Castellani et al., 2003) were also a concern.  
 
Table 1. Amino acid composition (mol %) of phosvitin sequences from the literature. 
 
Amino Acid Purified 
a 
Seq I
b 
Seq II
c
 Amino Acid Purified 
a 
Seq I
b 
Seq II
c
 
Asx 7.0 6.4 6.0 Tyr 0.6 1.6 0.5 
Glx 7.2 7.6 5.0 Val 1.9 1.6 1.4 
Ser 47.1 48.8 57.0 Met 0.6 0.4 0.5 
Gly 3.9 3.2 2.3 Cys 0.4 0.0 0.0 
His 5.5 4.0 6.0 Ile 1.1 0.4 0.9 
Arg 5.5 6.3 5.1 Leu 1.6 0.8 1.4 
Thr 2.3 4.0 1.8 Phe 1.0 2.0 0.5 
Ala 4.1 3.2 3.2 Lys 8.7 7.1 6.9 
a
Castellani et al., 2003; 
b
Mabuchi et al., 1996; 
c
Byrne et al., 1984 
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Structure of phosvitin  
Phosvitin is a highly unfolded flexible protein consisting of two polypeptide 
components, (alpha and beta) (Abe et al., 1982; Itoh et al., 1983; Vogel, 1983).  The main 
factor that influences the structure of phosvitin is pH.  At a physiological pH, phosvitin exists 
in a random coil conformation and at acidic pH the β conformation predominates (Vogul, 
1983; Yasui et al., 1989), which influences solubility of this glycoprotein (Table 2; Castellani 
et al., 2003).  Phosvitin is extremely hydrophilic with a proportionately lower amount of 
hydrophobic side chains (Figure 2), and possesses a net negative charge (Sattar Khan et al., 
2000).  At physiological pH phosphoserine residues are exposed and can be protonated or 
deprotonated depending on the chemical characteristics of the solvent (Vogul, 1983).  In 
acidic pH phosphoryl groups can shift from amide to ester linkages; whereas, at alkaline pH 
free amino groups become masked also causing phosvitin to release acid (Connely and 
Taborsky, 1961; Taborsky and Allende, 1962).  
 
Stability of phosvitin 
 Native phosvitin exhibits relatively good stability to heat, pressure and enzyme 
action.  Little or no change in structure or precipitation of this protein occurs at 100°C for 
several hours, concurrent with varying pH (4 to 8 pH) (Mecham and Olcott, 1949; 
Matsudomi et al., 2006).  Phosvitin is also not affected by high pressures up to 600 MPa 
(Castellani et al., 2004).  Phosvitin is not easily digested by pepsin, trypsin, and 
chymotrypsin.  In fact the core of the protein remains largely intact after enzymatic digestion, 
due to the negative charge of the phosphate group rendering the neighboring peptide bonds 
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resistant to proteolytic action (Goulas et al., 1996).  Dephosphorylation methods have been 
employed to enhance digesting phosvitin (Jiang and Mine, 2000, 2001). 
 
Table 2. Solubility of isolated phosvitin at different pH values. Source: Castellani et al., 
2003. 
  
 
 
          
    
  
a
Expressed in percent of N from lyophilized isolated protein 
   b
Standard deviation 
 
 
Figure 2. Structural schematic of hen egg yolk phosvitin. 
 
 
 
 
Hen egg yolk phosvitin, amino acid composition and structure provide a variety of functional 
(metal chelation) and biological properties (antioxidant and antimicrobial).  The primary 
structure of phosvitin makes it one of the strongest metal chelating glycoproteins 
(Grizzutiand Permann 1973; Hegenauer et al.; 1979; Castellani et al., 2004; Xu et al., 2007).  
 
Metal chelation 
The capacity of phosvitin to chelate metal ions, as well as peptides resulting from 
enzymatic digestion of this glycoprotein are major factors related on phosvitin’s influence 
pH % of solubility
a 
± SD
b
 
1.5 9.30 ± 4.2 
2.5 83.5 ± 1.7 
3.6 84.5 ± 1.5 
5.0 90.6 ± 2.5 
7.0 97.7 ± 1.4 
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mineral bioavailability.  Avian eggs are rich in iron and about 95% is bound by phosvitin 
(Greengard et al., 1964).  Almost all iron, calcium, and phosphorus are contained in the yolk 
(Taborsky, 1983; Watkins, 1995).  The numerous phosphorylated serine residues have a 
strong affinity for divalent metals and contribute to the chelating ability of phosvitin (Osaki 
et al., 1975; Grogan and Taborsky, 1987).  Phosvitin contains between 3 to 6 iron atoms per 
molecule depending on the method of isolation from hens’ eggs; however, it has a binding 
capacity of about 60 iron molecules (Mecham and Olcott, 1949; Taborsky, 1963; Webb et al., 
1973, Albright et al., 1984).  The iron binding capacity differs dependent on source of 
phosvitin, for example phosvitin in fish eggs have a lower iron binding capacity due to less 
phosphorus and serine content, and smaller size (Table 3; Guerdin-Dubiard et al., 2002). 
When iron binds with phosvitin an iron-phosvitin complex is formed, rendering phosvitin 
insoluble and the iron unavailable.  Phosvitin oxidizes Fe (II) to Fe(III) and also binds 
substantial amounts of Fe (III) (Osaki et al., 1975). 
Trypsin hydrolyzed phosvitin enhanced Ca-binding capacity and inhibited the 
formation of insoluble Ca phosphate (Jiang and Mine, 2001).  Ishikawa et al 2004 
investigated the effect of phosvitin on Fe (II)-catalyzed hydroxyl radical (•OH) formation 
from H2O2 in the Fenton reaction system.  Those authors reported that phosvitin accelerated 
Fe (II) autoxidation thus decreasing availability of Fe (II) participation in the •OH-generating 
Fenton reaction.  Phosvitin was also found to protect DNA against oxidative damage induced 
by Fe (II) and H202.  These results provide insight into the mechanism of protection of the 
developing embryo against iron-dependent oxidative damage in ovo.  Choi et al., 2005 
examined the effects of phosvitin and tryptic digests of phosvitin on the efficiency of 
enhancing calcium absorption and accumulation in the bones of rats.  Calcium absorption 
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was found to be greater with peptides from tryptic digestion of phosvitin; thus, increasing the 
bioavailability of Ca and accumulation in bone.  Ishikawa et al., 2007 demonstrated that 
native phosvitin decreased absorption of iron, calcium and magnesium, suggesting that 
mineral bioavailability is influenced by the following: the type of proteins (amino acid 
composition), its binding strength to minerals, and resistance to proteolysis.   
  
Table 3. Iron Binding properties of phosvitins. Source: Guerin-Dubiard et al., 2002. 
Phosvitin MW phosvitin (Da) Mol Fe/mol Phosvitin 
Sigma 35,000
a 
36.0 
Laboratory 35,000
a 
32.0 
*Ling #23,000
a 
9.5 
*Siki #25,000
a 
3.6 
a
MW were estimated from SDS-PAGE analysis 
*
Ling and Siki are phosvitin from fish 
 
Antioxidant and nutritional aspects 
Phosvitin plays an important role as an antioxidant in the yolk by inhibiting iron-
catalyzed lipid oxidation (Lu and Baker, 1986).  Various studies have observed the 
antioxidant properties of phosvitin and peptides derived from phosvitin; antioxidant potential 
findings were both negative and positive.  Phosvitin is efficient up to a Fe
2+
 to phosvitin 
ration of 30:1, and pH 6 provides its maximal antioxidant activity (Guerin-Dubiard et al., 
2002).  Antioxidant ability did not change when phosvitin was pasteurized (61.1 °C); 
however, autoclaving (121.1 °C, 10 min) phosvitin decreased inhibitory capacity on iron 
catalysis (Lu and Baker, 1986).  Native phosvitin has been considered nutritionally negative, 
in that it resists proteolytic actions (Goulas et al., 1996) and lowers bioavailability of iron 
(Morris and Greene, 1972) due to its highly phosphorylated structure.  It has been 
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demonstrated via both in vitro and in vivo experiments that yolk protein intake resulted in 
decreased mineral absorption and digestibility of the phosvitin in rats (Ishikawa et al., 2007). 
To by-pass the hurdle of low bioavailability of iron, phosvitin has been hydrolyzed to 
form smaller peptides (1-3kDa) following dephosphorylation (Jiang and Mine, 2000, 2001). 
The smaller peptides consist of about 35% of the phosphorus content of native phosvitin, 
indicating that the peptides would be individually less active than native phosvitin (Jiang and 
Mine, 2001).  Ishikawa et al., (2004) found phosvitin and digested phosvitin were more 
efficient antioxidants in inhibiting •OH formation compared to metal-binding proteins 
(ferritin, transferrin, lactoferrin, ovotransferrin, and bovine serum albumen), iron chelators 
(DFO-deferoxamine mesylate, NTA-nitriloacetic acid, EDTA-ethylenediamine tetraacetate, 
citrate, ADP, phytate) and hydroxyl radical scavengers (mannitol, thiourea, ethanol, DMSO). 
The tryptic digested phosvitin was as efficient an antioxidant as phosvitin towards inhibiting 
Fe (II) catalyzed •OH formation, indicating that both forms have iron-binding ability. Xu et 
al., 2007 also observed the antioxidant activities of intact phosvitin, and tryptic digests of 
phosvitin.  Those same researchers reported that digested phosvitin was more effective than 
intact phosvitin at inhibiting lipid oxidation in a linoleic acid system.  In addition, the 
digested form of phosvitin was efficient in radical scavenging activity on 2,2-diphenyl-1-
picrylhydrazyl induced free radicals; however, its chelating capabilities were relatively less 
effective. Antioxidant activity of phosvitin has been demonstrated in egg yolk emulsion as 
well as meat model systems (Lu and Baker, 1986; Lee et al., 2002).  Also phosvitin inhibited 
lipid peroxidation induced by UV irradiation in a dose-dependent manner in the presence of 
excess iron (Ishikawa et al., 2005).  These results suggest that phosvitin and peptides derived 
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from phosvitin might be useful for prevention of other iron-mediated oxidative stress related 
diseases, such as colorectal cancer (Katayama et al., 2006; Ishikawa et al., 2009). 
The mechanism of action of digested phosvitin is less understood, and is possibly 
influenced by peptide composition (histidine, methionine, and tyrosine) (Yamashoji et al., 
1979) or structure and not solely on the phosphorus content (native phosvitin postulation) 
(Hegenauer et al., 1979; Xu et al., 2007).  The aforementioned properties, illustrate the 
possibility of its commercial uses as a natural antioxidant.  
 
 
Antimicrobial properties 
 
The iron binding capabilities contribute to the antimicrobial properties of phosvitin. 
Iron is an essential element for all living organisms and interestingly, ninety-five percent of 
iron in hen’s egg yolk is bound by phosvitin in a very strong and stable conformation to 
avoid being used by microbes (Greengard et al., 1964).  To our knowledge there has only 
been one published study on the antimicrobial potential of phosvitin. Sattar Khan et al., 2000 
tested native phosvitin, a protease digested phosvitin fraction and phosvitin-galactomannan 
conjugate against Escherichia coli under thermal stress.  These authors reported that at 50 °C 
for 20 minutes in L-broth, both native phosvitin and phosvitin-galactomannan conjugate were 
significantly more effective than the control in decreasing the viability of the target 
organism; whereas, the digested fraction was not effective.  It was noted the antimicrobial 
properties of phosvitin could be reversed by the addition of Ca
2+ 
(Table 4) indicating that 
divalent cations may occupy sites on phosphate groups of phosvitin to prevent further 
binding of cations important in meeting the nutritional needs of the organism.  Antimicrobial 
activity of intact phosvitin is believed to be due to chelating abilities and surface activity 
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(affinity for outer membrane).  These activities in conjunction with thermal stress seem to 
contribute to the loss of viability of E. coli   (Sattar Khan et al., 2000). 
 
Table 4. Determination of Calcium Binding Capacity of 0.1% Native and Modified 
Phosvitins. Source: Sattar Khan et al., 2000. 
 
                                                                        bound calcium 
                                                                    mol/mol of phosvitin) 
Samples at pH 3.6 at pH 7.0 
Native phosvitin
a 
0 0 
Native phosvitin 20 148 
Phosvitin-galactomannan 
conjugate 
27 151 
 α-chymotrypsin-digested 
phosvitin   
17 118 
a
Phosvitin without calcium 
 
Plant-derived sources of antimicrobials 
The growing number of foodborne illness-related outbreaks due to human enteric 
pathogens is an increasing concern to regulatory agencies, the food industry, and consumers. 
While effective control of foodborne pathogens is crucial to ensuring microbial food safety, 
methods of control involving synthetic chemical preservatives are becoming less desirable to 
consumers.  This consumer attitude is part of a growing trend towards “Green Consumerism” 
emphasizing the reduction or elimination of preservative agents such as nitrite and sodium 
chloride from foods (Burt, 2004) and encouraging the use of herbs and spices with 
antimicrobial properties to preserve foods, promote healthier foods and improve food safety.  
 Herbs and spices have been used for centuries specifically for medicinal purposes, 
flavor, fragrances, and as natural preservative methods for a variety of foods (Achinewhu et 
al., 1995; Cowan, 1999). The majority of essential oils are classified as Generally 
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Recognized As Safe (GRAS).  From a food safety standpoint, the antimicrobial properties 
possessed by the essential oil components of herbs and spices have only been scientifically 
confirmed within the last 30 years (Olasupo et al., 2004).  The phenolic compounds in the 
essential oil fraction of the plant possess antimicrobial properties (Beuchat, 1994).  There 
have been numerous studies published addressing the antimicrobial properties of a wide 
variety of essential oils (Remmal et al., 1993; Hammer et al., 1999; Dorman and Deans, 
2000; Frieman et al., 2002; Burt, 2004).  Limitations to applications of essential oils as 
antimicrobial agents are mainly due to intense flavors and odors that effective antimicrobial 
concentrations may add to foods.  One approach that has been deemed useful is to determine 
the minimum inhibitory concentration (MIC) and apply the essential oil in combination with 
other antimicrobials or preservative methods to control foodborne pathogens.  Such an 
approach aims to take advantage of additive or synergistic effects of antimicrobial 
interventions.  
 
Carvacrol 
Source and structure 
Carvacrol, an essential oil, is found in the leaves and flowering plant of both thyme 
(Thymus vulgaris) and oregano (Origanum vulgare) (Burt, 2004; Oussalah, 2007).  The 
percent composition of carvacrol in oregano ranges from trace amounts to 82% and 2 to 45% 
in thyme (Lagouri et al., 1993; Arrebola et al., 1994; Burt, 2004).   Carvacrol [2-methyl-5-(1-
methylethyl) phenol] (Figure 3) is biosythensized from p-cymene and g-terpinene (Poulose 
and Croteau, 1978).  The hydrophobic phenolic compound in its structure is thought to be the 
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main contributor to its antimicrobial properties; however, other components of its structure 
may be also important in this regard (Veldhuizen et al., 2006). 
 
Figure 3. Structure of carvacrol - l [2-methyl-5-(1-methylethyl) phenol]. 
 
Antimicrobial activity 
Several studies have demonstrated that carvacrol has both bacteriostatic and 
bactericidal activity against microorganisms: Listeria monocytogenes (Pol and Smid, 1999; 
Karatzas et al., 2001, Friedman et al., 2002; Periago et al., 2004; Gaysinsky et al., 2005;  
Oussalah et al., 2006, Veldhuizen et al., 2007;  Solomakos et al., 2008; Perez-Conesa et al., 
2011), Bacillus cereus (Pol 1999; Ultee et al., 1998, 1999,  2000 a, b; Ultee and Smid, 2001),  
Escherichia coli  O157:H7( Helalnder et al., 1998; Friedman et al., 2002, 2004; Lacroix et 
al., 2004;  Gaysinsky et al., 2005;  Kisko and Roller, 2005; Oussalah et al., 2006; Juneja and 
Friedman 2008; Xu, 2008; Obaidat and Frank, 2009; Pei et al., 2009; Perez-Conessa et al., 
2011), Staphylococcus aureus (Knowles et al., 2005; Lambert et al., 2001; Oussalah et al., 
2006, 2007), Salmonella enterica  (Helander, 1998, Lacroix, 2004, Friedman et al., 2004; 
Knowles et al., 2005; Nazer et al., 2005; Zhou et al., 2007; Ravishankar et al., 2010), 
Campylobacter jejuni (Friedman et al., 2002), Clostridium perfringens (Juneja and Friedman, 
2007), Pseudomonas fluorescens (Lambert et al., 2001, Arfa et al., 2006; Di Pasqua et al., 
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2006), Lactobacillus plantarum  (Arfa et al., 2006),  Saccharomyces cerevisiae (Chami et al., 
2005, Arfa et al., 2006), Botrytis cinerea (Arfa et al., 2006), Shigella spp (Bagamboula et al., 
2004) and Candida albicans (Chami et al., 2005).  The minimum inhibitory concentrations of 
carvacrol for some foodborne pathogenic bacteria are shown in Table 5. 
 
Table 5. Minimum inhibitory concentration of carvacrol tested in vitro against selected 
foodborne pathogens. Adapted from Burt, 2004. 
 
Foodborne Pathogen Minimum Inhibitory 
Concentration (MIC)  range 
(ppm) 
References 
Escherichia coli 225 – 5000 Kim et al, 1995a; Cosentino 
et al 1999; Pei et al., 2009 
Salmonella typhymurium 150 – 250 Kim et al., 1995a; Cosentino 
et al., 1999; Nazer et al 2005 
Staphylococcus aureus 175 – 450 Cosentino et al., 1999, 
Lambert et al., 2001 
Listeria monocytogenes 375 – 5000 Kim et al., 1995a; Cosentino 
et al 1999; Pol and Smid, 
1999 
Bacillus cereus 187.5 – 900 Cosentino et al., 1999; Pol 
and Smid, 1999 
 
Carvacrol has been studied extensively in broth model systems as well as the following 
foods: cheese (Smith-Palmer et al., 2001), apple cider (Friedman et al., 2004, Kisko and 
Roller 2005), fruit (kiwi and melon) (Roller and Seedhar, 2002), carrot broth (Valero and 
Salmeron, 2003), salad (Koutsoumanis et al., 1999),  lettuce and spinach leaves (Obaidat and 
Frank, 2009), rice (Ultee et al., 2000b), turkey (Juneja and Friedman, 2007), meat 
(Veldjuizen et al., 2007,  Juneja and Friedman, 2008; Solomakos et al., 2008, Friedman et al., 
2009), fish/seafood (Kim et al., 1995; Meljlholm and  Dalgaard, 2002;  Ravishankar et al., 
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2010).  Like other antimicrobials there are several factors that influence the efficacy of 
carvacrol as a natural antimicrobial with concentration being the most important factor. 
When carvacrol is present at non-lethal concentrations (0.4mM) Bacillus cereus can adapt to 
carvarol at 30°C in growth medium (Ultee et al., 2000a).   
Carvacrol has been combined with other preservatives or preservative methods to control 
foodborne microorganisms.  It has been shown to have stronger antimicrobial effect with 
increased temperature and storage time, and at a lower pH (Burt 2004, Friedman et al., 2004). 
Some antimicrobials that have been combined with carvacrol to control foodborne 
microorganisms include p-cymene (Periago et al., 2004; Kisko and Roller, 2005), nisin (Pol 
and Smid, 1999; Olasupo 2004; Solomakos, 2008), thymol  (Nazer et al., 2005, Zhou et al., 
2007; Pei et al., 2009), eugenol (Nazar et al., 2005; Pei et al., 2009), citral (Nazer et al., 
2005), cinnamaldehyde (Zhou, 2007b) and EDTA (Zhou, 2007a).  Encapsulated carvacrol in 
surfactant micelles has been proven effective in inhibiting growth of Escherichia coli 
O157:H7 and Listeria monocytogenes (Gaysinsky et al., 2005; Perez-Conessa et al., 2011). 
Karatzas et al., 2001 reported that carvacrol and high hydrostatic pressure (HPP) acted 
synergistically in inactivating Listeria monocytogenes.  
 
Mode of action 
The effectiveness of carvacrol as a natural antimicrobial is well established; however, 
the mechanism of action is less understood and is believed to be associated with damage to 
the cell membrane.  The phenolic component of carvacrol has prompted research focused on 
its effect on structural and functional damage to cellular membranes (Sikkema et al., 1995, 
Sivropoulou et al., 1996, Ultee et al., 1999).  Permeability of the cell membrane is dependent 
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on the hydrophobicity of the solutes that have to cross the membrane and the composition 
(Sikkema et al., 1995).  Several methods have been used to investigate the antibacterial 
mechanism of action of carvacrol: spectrofluorometry (Ultee et al., 1999, 2002; Lambert, 
2001), scanning electron microscopy (Kwon et al., 2003; Di Pasqua et al., 2007), confocal 
laser scanning microscopy (Gill and Holly, 2006) and flow cytometry (Xu et al., 2008). 
Results of those studies suggest that the antimicrobial mechanism of action of carvacrol is 
linked to alterations of cellular membranes.  
Lambert et al. (2001) determined that the addition of low levels of carvacrol (6.7 
mM) against Psuedomonas aeruginosa and Staphylococcus aureus increased permeability of 
cells to nuclear stain ethylene bromide, dissipated pH gradients and caused leakage of 
inorganic ions.  Arfa et al., 2006 investigated the relationship between the chemical structure 
of carvacrol, and carvacrol derivatives (carvacrol methyl ether and carvacryl acetate) against 
Escherichia coli, Pseudomonas fluorescens, Staphylococcus aureus, Lactobacilus plantarum, 
Bacillus subtilis, Saccharomyces cerevisiae and Botrytis cinerea.  The carvacrol derivatives 
were not effective antimicrobials and indicated the importance of the free hydroxyl group in 
antimicrobial activity of carvacrol. Carvacrol’s hydrogen bonding ability and proton 
releasing ability caused cell death due to membrane modification; however, this was not seen 
with carvacrol derivatives. Carvacrol caused a rapid decline in cellular ATP and 
corresponding increase in extracellular ATP of glucose energized Bacillus cereus (Ultee et al 
1999), Escherichia coli (Helander et al., 1998, Fitzgerald et al., 2004), Listeria innocua 
(Fitzgerald et al., 2004) and Salmonella typhimurium.  Ultee et al. (2002) proposed that 
carvacrol also acts as a proton exchanger, by exchanging its hydroxyl proton for another ion 
such as potassium.  Xu et al. (2008) concluded that carvacrol damages the cellular membrane 
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and reported that flow cytometry could be used to determine other targets (sensitive sites) to 
elucidate the true underlying antimicrobial effect of carvacrol.  Saccharomyces cerevisiae 
membrane was damaged by oregano essential oil which contains carvacrol (Chami et al., 
2005).  Damage to the cell membrane of that yeast was shown by the release of substances 
absorbing at 260 nm, as well as by scanning electron microscopy.  Gill and Holly (2006) 
demonstrated that carvacrol inhibited motility, disrupted the cytoplasmic membrane and 
inhibited ATPase activity in both Escherichia coli and Listeria monocytogenes.  They also 
suggested that membrane disruption may be a secondary effect rather than the primary effect. 
Analysis of lipid profiles of bacterial cells (Escherichia coli O157:H7, Staphylococcus 
aureus, Salmonella Typhimurium, Pseudomonas fluorescens, and Brochothrix 
thermosphacta) by gas chromatography showed a decrease of unsaturated fatty acids, 
particularly C18:2 trans and C18:3 cis after being exposed to carvacrol (Di Pasqua et al., 
2007).  Those same authors attributed that decrease in unsaturated fatty acids to membrane 
alterations noticed in scanning electron microscope images.  
 
Nisin 
There are several published reviews on nisin (Hurst, 1981; Ray, 1992; Hurst and 
Hoover, 1993; Delves-Broughton and Gasson, 1994; Delves-Broughton et al., 1996; Wessels 
et al., 1998; Thomas et al. 2000; Abee and Delves-Broughton, 2003; Juncioni de Arouz et al., 
2009; Chu et al., 2010).  Accordingly, this writing is not intended to be a comprehensive 
review on nisin but will briefly discuss source, composition and structure, antimicrobial 
activity, and mode of action of this bacteriocin.  
Source  
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Nisin, a bacteriocin, was first discovered in England 1928 by Rogers and Whittier.  
It is produced as a defense response to some lactic acid bacteria (LAB), specifically 
Lactococcus lactis subspecies lactis (Juncioni de Arouz et al., 2009).  The use of nisin as a 
suitable food preservative was first demonstrated by Hirsch et al. in 1951.  To date, nisin is 
the only Generally Recognized As Safe (GRAS) commercially available bacteriocin 
approved for use as a preservative additive in over fifty countries (FAO/WHO, 1969; FDA, 
1988; Jay, 2000).  Nisin can be made synthetically (Fukase et al., 1988) or naturally 
produced from culture fluids or cells of the originating organism during fermentation of a 
modified milk medium (Cheeseman and Berridge, 1957; Bailey and Hurst, 1971; Lee and 
Kim, 1985). Nisaplin® (produced by Danisco) and Chrisin are commercial fermentates 
prepared by using wild-type isolates of Lac. lactis subsp. lactis. 
 
 
Composition and structure 
 
Nisin is a categorized as a Class I lantibiotic.  It is a small cationic, amphiphillic 
polypeptide containing lanthionine and methyllanthione groups (Klaenhammer, 1993).  It is 
very flexible in structure and normally present in the more stable dimer form.  The monomer 
of nisin has a molecular weight of 3.5 kDa and contains 34 amino acids residues.  There are 
two forms of nisin produced, A (Figure 4) and Z. The two forms differ only by the number of 
histidines present; form A has two and Z has one.  In variant Z the histidine at position 27 is 
exchanged for asparagine, thus increasing its solubility and diffusion characteristics of nisin 
(Mulders et al., 1991; De Vos et al., 1993; Laridie et al., 2003).  The unusual amino acids are 
thought to be responsible for the functional properties of nisin (ex. acid tolerance, 
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thermostability at low pH, antimicrobial activity, and bactericidal mode of action) (Sahl, 
1991; De Vuyst and Vandamme, 1992).  
 
 
 
Figure 4. Structure of nisin form A. ABU, aminobutyric acid; DHA, dehydroalanine; 
DHB, dehydrobutyrine (β-methyldehydroalanine); ALA-S-ALA, lanthionine; ABU-S-
ALA, β-methyllanthionine. Source: Gross and Morrell, 1971. 
 
 
Antimicrobial spectrum 
 
Nisin has been used as a natural antimicrobial peptide and is effective against gram 
positive bacteria, including its producer organism.  The sensitivity of vegetative cells and 
spores to nisin may vary between strains within the same species of the following Genera of 
bacteria: Alicyclobaccillus (Komitopoulou et al., 1999), Bacillus (Jaquette and Beuchat, 
1998), Brochothrix (Cutter and Siragusa, 1996), Clostridium (Okereke and Montville, 1992), 
Enterococcus (Laukova, 1995), Lactobacillus (Chun and Hancock, 2000) Listeria (Knight et 
al., 1999), Micrococcus (Dutreux et al., 2000), and Staphylococcus (Thomas and Wimpenny, 
1996).  Gram-positive strains that are resistant to nisin have the ability to synthesize the 
enzyme nisinase which degrades nisin (Abee et al., 1995).  Nisin is unable to penetrate the 
cell wall of yeast.  Gram-negative bacteria are resistant to nisin; the antimicrobial is unable to 
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penetrate the complex cell wall, particularly the outer lipopolysaccharide membrane, to reach 
the cytoplasmic membrane (Kordel et al., 1989; Boziaris and Adams, 1999).  
Combinations of nisin and other antimicrobial have been reported to have substantial 
inhibitory or killing effects against bacteria.  Nisin has been successfully combined with 
other bacteriocins such as pediocin (Cabo et al., 2009) and leucocin F10 ( Parente et al., 
1998), the plant essential oils carvacrol (Pol and Smid, 1999) and thymol (Solomakos et al., 
2008), lysozyme (Chun and Hancock, 2000; Mangalassary et al., 2007), EDTA (Branen and 
Davidson 2004; Ukuku et al., 2009), heat (Beard et al., 1999), pulsed electric fields (Dutreux 
et al., 2000), and high pressure treatment (Yuste et al., 1998).  Nisin alone is not effective 
against gram negative bacteria.  When nisin is combined with hurdle technology (Figure 5) 
its antimicrobial efficiency is enhanced by either synergistic or additive effects against both 
gram negative and gram positive microorganisms.  Hurdle technology also offers the 
opportunity to provide an additional barrier and avoid the development of resistant strains. 
 
Figure. 5. Application of bacteriocins as part of hurdle technology. Source: Galvez et al., 
2007. 
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Mechanism of action 
Numerous studies have addressed the mechanism of action of nisin (Ramsier, 1960; 
Gao et al., 1991; Bruno and Montville, 1993; Mol et al., 1996, 1997; Hasper et al., 2006).  In 
susceptible vegetative cells the primary site of action by both A and Z forms is the 
cytoplasmic membrane (Abee et al., 1995; Kuwano et al., 2005).  Nisin has the ability to bind 
the membrane and form pores that destroy the membrane integrity.  Pore formation leads to 
leakage of K+ ions and ATP, depletion of the proton motive force, and depolarization of 
transmembrane potential, resulting in cell death (Sahl, 1991; Bruno and Montville, 1993; 
Millette et al., 2004).  It has also been reported that nisin interferes with cell wall 
biosynthesis by binding with lipid II, a peptidoglycan precursor (Mantovani and Russell, 
2001; Bauer and Dicks, 2005; Kruijff and Breukink).  Cells with low levels of lipid II have 
been found to be less sensitive to nisin (Brotzel et al., 1998). 
 
Foodborne human enteric pathogens 
 More than 250 known diseases are transmitted through food and foodborne diseases 
are a widespread and growing public health problem, both in developed and developing 
countries.  The Center for Disease Control reports that foodborne diseases previously caused 
approximately 76 million illnesses, 325,000 hospitalizations, and 5,000 deaths in the United 
States each year (Mead et al., 1999).  Known pathogens account for an estimated 14 million 
illnesses, 60,000 hospitalizations and 1,800 deaths (Mead et al., 1999).  Recent data reports 
that foodborne disease related illnesses has declined annually causing approximately 9.4 
million episodes, 55,961 hospitilizations, and 1,351 deaths (Scallan et al., 2011).  Bacteria 
are a common cause of foodborne illness.  In the past, typical examples of food transmission 
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vehicles were raw meats, chicken, eggs, juices, milk, and ready-to-eat meat etc.  More 
recently other types of food products including vegetables, peanut butter, and spices have 
been incriminated in disease outbreaks (Natvig et al., 2002).  The following human enteric 
pathogens among those that are of great concern to federal health agencies, food processors 
and consumers are Escherichia coli O157:H7, Listeria monocytogenes, Salmonella enterica 
and Staphylococcus aureus (Kotula et al., 2000). 
 
Escherichia coli 
Morphology and characteristics  
Escherichia coli is a part of the Enterobacteriaceae family.  It is morphologically 
classified as a Gram-negative, non spore-forming, motile or nonmotile straight rod (1-4µm). 
It is a mesophilic, facultative anaerobe that is a normal inhabitant of intestines of humans and 
other warm-blooded animals (mammals and birds).  E. coli is an indicator organism and its 
presence in food or water is generally indicative of fecal contamination.  There are several 
pathogenic strains of E. coli that can be placed into 6 groups: 1) enterotoxigenic (ETEC), 2) 
enteroinvasive (EIEC), 3) enteroaggregative (EAEC), enteropathogenic (EPEC), diffusely 
adherent (DAEC), and enterohemorrhagic (EHEC) (Buchanan and Doyle, 1997; Ray, 2004).   
The Escherichia coli O157:H7 used in experiments described in the present dissertation 
belong to the EHEC group which is known to cause hemorrhagic colitis in infected persons.  
Apart from E. coli O157:H7 there are other major non-O157:H7 EHEC serotypes including 
O157:NM, O111:H8, and O26:H11 (Meng et al., 2001); however, the information in the 
following paragraphs will mainly focus on E. coli O157:H7 because it is the most common 
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serotype in the EHEC group and there are far more published reports on this serotype than 
other EHEC serotypes. 
 
Escherichia coli O157:H7 
In 1982 Escherichia coli O157:H7 was first associated with two outbreaks of 
hemorrhagic colitis (Wells et al., 1983).  Although other E. coli serotypes such as O111, 
O26, and O126:NM (a sorbitol fermenting serotype) have been since linked to cases of 
hemorrhagic colitis, E. coli O157:H7 is the major cause of EHEC-associated illness in the 
United States and several countries (Meng et al., 2001).  Just like all other EHEC serotypes, 
this pathogen produces Shiga-like toxin (Stx) or verotoxin (VT) (Johnson et al., 1983; 
Karmali et al., 1985).  Escherichia coli strains that produce Shiga toxin are called Shiga 
toxin-producing E. coli (STEC) because of the strong similarity between the toxin they 
produce and the toxin produced by Shigella dysenteriae type 1 (Calderwood et al., 1996).  
Over 200 non O157:H7 serotypes of STEC were isolated from humans; however, only those 
isolates that cause hemorrhagic colitis are classified as EHEC.  Other characteristics of E. 
coli O157:H7 include inability to ferment sorbitol within 24 hours, optimum growth within 
30 to 42°C and pH 6 to 8, and acid tolerance although optimal pH for growth is between 6 
and 8 (Tsai and Ingham, 1997).  In addition, this pathogen is unable to grow well, if it does, 
at temperatures > 44.5 C in E. coli broth.  It does not produce β -glucuronidase (GUD), 
therefore it is unable to hydrolyze 4-methylumbelliferyl-D-glucoronide (MUG), a 
fluorogenic substrate that is hydrolyzed by E. coli to produce the fluorescent 4-
methylumbelliferyl moiety that fluoresces under long wave ultra violet light.  This reaction 
helps in differentiation of E. coli from other organisms although a few salmonellae, shigellae 
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and some corynebacteria are GUD positive.  Escherichia coli O157:H7 has an attaching and 
effacing (eae) gene and possesses a 60-MDa plasmid (Griffin, 1995).  This pathogen can 
easily be destroyed by pasteurization or cooking (Williams and Ingham, 1997) therefore, 
undercooking and/or post-cook contamination of certain foods such as ground beef are 
factors that drastically increase the risk of foodborne infection by this pathogen. 
 
Reservoirs 
 Cattle are a major reservoir for E. coli O157:H7.  Orskov et al. (1987) reported the 
first isolation of E. coli O157:H7 from a calf (less than three weeks old) with coccobacillosis 
in Argentina.  Generally, the prevalence of E. coli O157:H7 in cattle is about 10 to 25%.  
Interestingly, the isolation rates are much lower for non- O157 STEC.  Based on results of 
two major surveys conducted in the United States, 31 (3.2%) of 965 dairy calves and 191 
(1.6%) of 11,881 cattle on feedlots tested positive for E. coli O157:H7 (Zhao et al., 1995).  
Adult cattle seem to carry less E. coli O157:H7 than young cattle.  In the feces of calves, 
populations of this pathogen range from detectable via enrichment culture (< 10
2
 CFU/g) to 
10
5
 colony forming units (CFU)/g.   
During the warmer months of the year there is a higher prevalence of the pathogen in 
cattle that correlates with the seasonal variation in E. coli O157:H7 infections in humans.   In 
England, 38% of cattle delivered for slaughter in the spring tested positive for E. coli 
O157:H7 whereas, only 4.8% of cattle were positive for this pathogen during the winter 
season.  Similarly a study in the United States revealed a high prevalence of the pathogen in 
cattle delivered for slaughter during July to August 1999 (Elder et al., 2000).  Escherichia 
coli O157:H7 is not a pathogen of calves or adult cattle; therefore, cattle that harbor this 
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pathogen are not ill.  Although, in some instances E. coli O157:H7 was linked to diarrhea and 
attaching and effacing lesions in new born calves (Cray et al., 1995; Dean-Nystrom et al., 
1997). 
 Apart from cattle several domestic animals and wildlife including dogs, cats, horses, 
sheep, goats, pigs and deer, have been found to harbor E. coli O157:H7 and other STEC.  
These microorganisms were also found in rats and seagulls (Cizek et al., 1999; Wallace et al., 
1997).  Compared to other animals, sheep seem to have the highest prevalence of E. coli 
O157:H7 and STEC.  Results of a survey of seven animal species in Germany revealed that 
STEC were most frequently isolated from sheep (66.6%), goats (56.1%), and cattle (21.1%).  
A much lower frequency of isolation of the pathogen was reported for cats (13.8%); pigs 
(7.5%), dogs (4.8%) and chickens (0.1%) (Beutin et al., 1993). 
 Humans can carry and shed E. coli O157:H7 for a substantial amount of time.  In 
patients with hemorrhagic colitis or hemolytic uremic syndrome (HUS) the fecal shedding of 
this pathogen typically lasts for approximately 13 to 21 days after the onset of symptoms.  
Karch et al. (1995) reported that a child who was infected during an E. coli O157:H7 
outbreak at a day care center continued to shed the pathogen for 62 days after the onset of 
diarrhea.  To date no asymptomatic long term carriage of the pathogen in humans has been 
reported.  Fecal carriage of the E. coli O157:H7 in humans is important because of the 
potential for person-to-person spread of this pathogen which has a low infectious dose (< 100 
cells). 
 
Foodborne Outbreaks 
 In the late 1800s E. coli was considered to be relatively harmless.  An outbreak that caused  
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infants to have diarrhea in the mid 1940s resulted in some strains of E. coli being designated 
as enteropathogenic.  This organism has been implicated as the contaminant in a variety of 
foods related to food recalls and foodborne illness.  In 1982, E. coli O157:H7 was first 
recognized as a foodborne pathogen after an outbreak of hemorrhagic colitis associated with 
the consumption of hamburgers (Riley, et al., 1983).  In 1993 consumption of contaminated 
hamburgers from restaurant chains caused 700 illnesses and 4 deaths across 4 states, the 
largest documented E. coli outbreak in the United States (Wachsmuth et al., 1997). United 
States Department of Agriculture division of Food Safety and Inspection Service identified 
E. coli O157:H7 as an adulterant in ground beef and instituted a sampling program to test for 
the pathogen in federally inspected establishments and retail stores in October 1994 (Griffin 
et al., 1994).  The following food vehicles have been linked to E. coli O157 contamination: 
ground beef (Firstenberg-Eden and Sullivan, 1997), venison, sausage, dried uncooked salami, 
unpasteurized milk and cheese, unpasteurized apple juice and cider (Cody et al., 1999), 
orange juice, vegetables (alfalfa, parsley, radish sprouts, lettuce, cabbage, and spinach) 
(Breuer et al., 2001), fruits and berries, nuts and cookie dough.  Until recently any outbreak 
of E. coli O157:H7 was assumed to be linked to raw or undercooked meat, specifically beef. 
 
Characteristics of the disease 
Escherichia coli O157:H7 infection occurs after ingestion of food contaminated with 
the pathogen and can result in diarrhea (non-bloody), hemorrhagic colitis (HC), hemolytic 
uremic syndrome (HUS), and thrombocytopenic purpura (TTP).  The infectious dose (< 50 
cells) to cause severe clinical syndromes is very low compared to that of several other 
foodborne pathogens (Bell, 2002; Ray, 2005).  The incubation period is usually 3 to 4 days 
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with a range of 2 to 12 days.  During this time the pathogen colonizes the large intestine and 
binds tightly to cells in the intestinal lining.  During the first two days of illness infected 
persons experience non-bloody diarrhea and abdominal cramps that progresses to bloody 
diarrhea that may last for four to ten days (Besser et al., 1999).  Usually, symptoms regress 
and stop after about one week; however, approximately 6% of infected individuals develop 
HUS with half of them requiring dialysis and 75% requiring blood transfusion (Cohen, 1996; 
Ref 32, Frontiers).  Some patients endure kidney damage and occasionally kidney failure, 
seizures, coma and may die (Martin et al., 1990; Bell et al., 1994; Boyce et al., 1995; 
MacDonald et al., 1998).  The fatality rate due to human infection with this pathogen is about 
1% (Besser et al., 1999) 
 
Listeria monocytogenes 
Morphology and characteristics 
Listeria monocytogenes is Gram-positive, non-spore-forming, short, roundended rod-
shaped (0.5 x 1 µm) bacterium which is motile (at 28 °C) by means of peritrichous flagella.  
This organism is a psychrotrophic, facultative anaerobe, occurring singly or in short chains 
and belongs to the Listeriaceae family.  The genus Listeria is separated into the following six 
species based on DNA relatedness: 1) Listeria monocytogenes – human pathogen, 2) Listeria 
ivanovii – pathogen in sheep, 3) Listeria innocua – non pathogenic, 4) Listeria welshimeri, 5) 
Listeria seeligeri, and 6) Listeria grayi.  Listeria monocytogenes has several serotypes: 1/2a, 
1/2b, 1/2c, 3a, 3b, 3c, and 4a, 4ab, 4b, 4c, 4d, 4e, and 7.  While all serotypes are capable of 
causing disease in humans, serotypes 1/2a, 1/2b and 4b are responsible for about 95 to 98% 
of documented human listeriosis cases (Lund et al., 2000). 
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Listeria monocytogenes has the ability to adapt and survive exposure to many 
environmental stresses.  This pathogen can survive and grow in a wide temperature range -
1.5 to 45°C (Juntilla et al., 1988; Vasseur et al., 1999); with optimal growth at 35 to 37 °C. 
Refrigeration temperature leads to delayed growth (Rosenow and Marth, 1986). This 
pathogen can also tolerate reduced water activity (< 0.93) by freezing or drying (Farber et al., 
1992; Mena et al., 2004), high salt concentrations (up to 30%), acidic pH (below 5.0) (Bacon 
and Sofos, 2003), and nitrite concentrations currently approved for use in foods (ICMSF, 
1996; Murray et al., 1999).  These characteristics contribute to its survival under conditions 
usually adequate to control the growth of pathogens in food.  Listeria monocytogenes is 
readily killed by conventional thermal processing of foods with prolonged exposure to 
elevated temperatures (above 56 °C) causing irreversible cellular damage resulting in death 
of the organism (Bunduki et al., 1995).   
 
Reservoirs 
 Listeria is ubiquitous in the natural environment and therefore there are several 
environmental reservoirs of this pathogen.  It has been isolated from soil, sewage, water, 
dead vegetation, human and animal feces, food processing facilities and animal feed 
(Beresford et al., 2001; Teixeira et al., 2008).  Soils with decaying vegetation and/or 
fertilized with animal excreta or sewage sludge are highly likely to harbor L. monocytogenes.  
Interestingly, the natural habitat of this pathogen seems to be decaying vegetation such as 
aerobically spoiled silage, which supports prolific growth of this pathogen and serves as a 
source of listeriosis in farm animals (Fenlon, 1996).  Due to L. monocytogenes’s widespread 
occurrence in nature, many feral and domestic animals carry this pathogen in their lymph 
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nodes and/or in their intestinal tract.  About 11 to 52% of animals are carriers of this 
pathogen; pigs (45%) and cattle (24%) were found to carry the pathogen in their tonsils and 
pharyngeal lymph nodes, respectively (Doyle et al., 2007).  Approximately 5 to 10% of 
humans exhibit intestinal carriage of this pathogen without any overt symptoms (Lorber, 
1997). 
 Listeria monocytogenes can enter food processing facilities by several vehicles 
including raw agricultural products of plant or animal origin, clothing and shoes of workers, 
and possibly air-borne dust.  Once this hardy pathogen enters the food processing 
environment it is easily spread to several areas by movement of raw materials, workers, 
tools, wheels of carts and actions that cause cross-contamination.  L. monocytogenes is 
commonly found in moist areas such as floor drains, condensates on pipes, stagnant water, 
and residual food material on food processing equipment (Ryser and Marth, 2007). 
 
Foodborne outbreaks 
Listeria monocytogenes was first recognized as a human pathogen in 1929; however, 
it emerged as a serious food-borne pathogen in the 1980s and has been increasingly 
associated with food recalls and foodborne listeriosis outbreaks (Teratanavat and Hooker 
2004).  Five of the largest listeriosis outbreaks occurred in 1981 (Canada), 1983 (New 
England), 1985 (California), 1989 (multistate), and 2002 (multistate). In 1981, an outbreak 
related to consumption of contaminated coleslaw, resulted in 34 infected pregnant women, 9 
of which experienced stillbirths, 23 had infected infants, and 2 had healthy births. There were 
77 other adults who developed listeriosis with nearly 30% mortality. The outbreak in 1983 
was caused by drinking a specific brand of pasteurized whole or 2% milk contaminated by L. 
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monocytogenes serotype 4b, resulted in 49 patients acquiring listeriosis; 7 fetuses or infants 
and 42 immunocompromised adults; of these 14 patients died (Fleming et al., 1985). In 
California (1985), 142 people developed listeriosis from consuming a certain brand of 
pasteurized soft cheese that had been cross contaminated with raw milk during the 
manufacturing process. Of those 93 cases were perinatal, 49 non pregnant, and 48 
immunosuppressed individuals, of which 30 fetuses or newborn infants and 18 adults died 
(ICMSF, 1996). The 1989 multistate outbreak linked to meat frankfurters, resulted in 108 
cases, with 14 associated deaths and 4 miscarriges or stillbirths (Mead et al., 2006).  In 2002, 
a multistate outbreak of L. monocytogenes infection with 46 culture-confirmed cases, seven 
deaths, and three stillbirths or miscarriages in eight states was linked to eating sliced turkey 
deli meat. USDA established a zero tolerance policy for L. monocytogenes in ready-to-eat 
meat products (USDA, 1987, 1989).  Many different foods have been associated with being 
contaminated with L. moonocytogenes: minced meats, improperly cooked chicken, dairy 
products, fish and seafood, eggs, paté, pork, rice salad, butter, and potato salad (Schlech et 
al., 1983; Cox 1989; Schuchat et al., 1992; Vasseur et al. 1999; Rocourt et al., 2000; Pawar et 
al., 2000; Ryser and Marth, 2007).  Listeria is responsible for the foodborne illness listeriosis 
and is of significant concern to the food industry (Cox, 1989; Wong, 1998).  
 
Characteristics of listeriosis 
Listeriosis, an opportunistic disease, represents a small fraction of all illnesses related 
to bacterial foodborne pathogens but accounts for 3.8% of hospitilizations and 27.6% of 
deaths (Mead et al., 1999).  Foodborne infection occurs after consuming contaminated food, 
enabling listeria to penetrate the epithelial lining and cross the intestinal barrier. The 
pathogen is believed to become attached to epithelial cells of the GI tract by means of D-
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galactose residues on the bacterial surface which adhere to D-galactose receptors on the host 
cells (Dramsi et al., 1993).  The organism becomes engulfed by macrophages and encased in 
a vacuole.  Within the macrophage the pathogen eventually lyses the vacuole and invades the 
cytoplasm, where it begins to multiply.  A virulence factor that helps the pathogen to escape 
from the vacuole is listeriolysin O (LLO), and hemolysin which produces a zone of beta-
hemolysis around the listerial colony on blood agar (Lorber, 1997; Salyers and Whitt, 2002).  
The internalized pathogen is transported to lymph nodes then to the liver, which is a primary 
area of infection.  Within the macrophage the pathogen can spread through the bloodstream 
to other body tissues also while being protected from the host’s antibodies. Except for 
macrophages which are naturally phagocytic, other host cells such as enterocytes are invaded 
by the pathogen via special membrane proteins (In1A and In1B) called internalins (Gaillard 
et al., 1991) which facilitate adhesion to and invasion of the host cell (Lorber, 1997; Salyers 
and Whitt, 2002).   
Spread of L. monocytogenes in the human body can cause infection at several sites 
leading to septicemia, meningitis, abortions and stillbirths, gastroenteritis and death. 
Listeriosis is regarded as a major problem especially in high risk groups including pregnant 
women, fetuses, neonates, the elderly and immunocompromised individuals (30 to 40% 
fatality) (Farber and Peterkin, 1991).  L. monocytogens is one of very few infectious 
microorganisms that are capable of traversing the placental barrier and infesting the fetus.  
An infected pregnant woman may experience mild flu-like symptoms; however, the fetus 
usually develops a systemic infection, which is highly lethal (Lorber, 1997). The tragic 
reality of listeriosis in pregnant women is that there is no early warning sign of the disease.  
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The only first symptom is an infected neonate or a stillborn infant.  In immunocompromized 
individuals, the first sign of listeriosis infection is usually fever and the disease rapidly 
progresses to other complications, commonly meningitis (Lorber, 1997).  Healthy individuals 
may not develop symptoms or show very mild symptoms.  Common symptoms for healthier 
individuals are mainly enteric (abdominal cramps, diarrhea, nausea) along with a slight fever 
and headache. A major reason why listeriosis is an uncommon disease among 
immunocompetent persons is that the pathogen has a relatively high infectious dose (ID50).  
The ID50 is a measure of infectivity and refers to the number of viable cells of the pathogen 
required to cause infection in 50% of experimentally infected animals.  Due to the high ID50 
of L. monocytogenes, healthy persons have to ingest large numbers of viable cells of the 
pathogen to contract a mild infection. Treatments such as antacids or H2 blockers that 
compromise the acid protection in the stomach can increase a person’s susceptibility to 
listeriosis.  Pregnancy also increases a person’s susceptibility to this foodborne infection 
(Lorber, 1997).  Symptoms of listeriosis appear between 11 and 70 days (average 30 days) 
after ingestion of contaminated food.  This protracted incubation period presents a major 
impediment to accurately tracing the source of an outbreak because people are unable to 
accurately recall food consumed 30 days ago (Broome, 1993).   
 
Salmonella 
Morphology and characteristics 
Salmonella is a genus of the Enterobacteriaceae family.  It is morphologically 
classified as a Gram-negative, non spore-forming, usually motile, medium rod (1 x 4 µm). 
The normal habitat, of this mesophilic, facultative anaerobe is the gastrointestinal tract of 
animals, birds, insects, and some reptiles (turtles and frogs).  The Salmonella genus is 
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divided into two species, Salmonella enterica and S. bongori. S. enterica is further divided 
into six subspecies: (I) S. enterica subsp. enterica, (II) S. enterica subsp. salame, (IIIa) S. 
enterica subsp. arizonzae, (IIIb) S. enterica subsp. diarizonae, (IV) S. enterica subsp. indica, 
and (IV) S. enterica subsp. houtenae (Porwollik et al., 2004; Ray 2004).  Within subspecies I 
there are over 2500 serovars and all are considered human enteric pathogens. 
The growth range for Salmonella is from 5-46°C and optimum growth temperature is 
between 35 and 37°C.  Salmonella are generally sensitive to heat (pasteurization temperature 
and time) and high acidity (pH 4.5 or below), depending on food product and processing.  
Heat resistance can be developed in dry products (powdered milk) or low water activity 
products (peanut butter - aW < 0.35) (Burnett et al., 2000; Shacher and Yaron, 2006).  As the 
water activity decreases in a food product the pathogen becomes more heat resistant.  As with 
other pathogens food composition (fat and protein content) must be considered when 
determining possible heat resistance of Salmonella.  The cells also have the ability to survive 
(not multiplying) in suboptimal (frozen, dried, or nutrient starved) states for long periods 
(Foster and Spector 1995). 
 
Reservoirs  
 The widespread occurrence of Salmonella in the natural environment is most likely 
attributed to several reservoirs of this pathogen.  The continued prevalence of Salmonella in 
the global food chain is due to the pathogen’s widespread occurrence along with intensive 
production practices employed by poultry, cattle, swine, fish and shellfish industries and the 
recycling of animal visceral organs and inedible raw materials into animal feeds (D’Aoust, 
2000).  For several decades, poultry and poultry products have been well known as important 
 37 
 
reservoirs for salmonellae and have obscured the importance of meats including beef, pork, 
and mutton as potential sources of Salmonella infection in humans (Hedberg et al., 1999; 
Todd, 1994; World health Organization, 1988).  In its attempt to address this problem, the 
USDA Food Safety and Inspection Service (FSIS) published the “Final Rule on Pathogen 
Reduction and Hazard Analysis and Critical Control Point (HACCP) Systems” in July 1996.  
According to the Final Rule the meat and poultry processors are required to implement 
HACCP plans and systematically sample final products for fecal indicator (Escherichia coli 
biotype 1).  Also, FSIS performs testing of the finished meat products for Salmonella to 
ascertain that the HACCP system is adequate to control of this pathogen.  Before 
implementation of the Final Rule, the Salmonella contamination rate in processed broiler 
chickens was 24%.  By 1999 the contamination rate decreased to approximately 11%.  In a 
more recent survey of 20 U.S. broiler processing plants, the contamination rate was 20% for 
post-chill carcasses (Berrang et al., 2009).  Based on these findings, future improvement in 
reducing prevalence of Salmonella in meat and poultry products will require stringent control 
measures on animal production farms, and during processing, distribution and handling at 
retail sites. 
 Apart from poultry and other meats, eggs have been frequently identified as a 
reservoir of Salmonella and a vehicle for the spread of the pathogen in humans.  The 
pandemic linked to Salmonella enterica serotype Enteritidis phage type 4 and phage type 8 in 
Europe and North America, respectively, has been associated with the consumption of eggs 
(raw or lightly-cooked) and egg-containing products.  This pandemic further justifies the 
need for continued stringent pathogen control measures in poultry and egg production.  More 
focus should also be placed on pathogen control in breeder flocks because it is known that S. 
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Enteritidis can infect the ovaries of laying hens and enter the egg before the shell is 
produced.  This process is termed transovarian transmission in which the infective agent 
contaminates the egg prior to deposition of the shell.  Obviously, no amount of surface 
sanitizing of whole eggs can destroy the pathogen which is inside of the egg and remains 
viable. 
 Intensive fish farming involving improper management practices have created a 
relatively new reservoir of Salmonella.  Within the past three decades there has been an 
increase in aquaculture of various fish and shellfish species globally as alternative sources of 
these food products.  This trend resulted from the noticeable depletion of feral stocks of fish 
and shellfish and led to intensive (high-density) inland farming of these fish to satisfy the 
growing consumer demand. This type of intensive aquaculture has contributed to the 
widespread contamination of fish in unprotected earth, concrete, or other types of ponds that 
are continuously exposed to environmental contaminants.  In the U.S. a substantial amount of 
aquaculture products are imported from south American, Asian, and African countries where 
aquaculture farmers may be using questionable management practices that may increase the 
populations of salmonellae in pond-raised fish.  In some countries it is common practice to 
feed pond-raised fish with raw pieces of meat, offal, night soil and/or animal feeds that may 
be contaminated with various serovars of S. enterica.  The feeding of pond-raised fish with 
night soil is a serious public health concern because that type of feed could potentially carry 
typhoid and paratyphoid salmonellae.  Such practices perpetuate the occurrence of high 
populations of salmonellae and other human enteric pathogens and create a constant source 
of contamination in the production environment (D’Aoust, 1994).  In addition, they at times 
increase the populations of fish pathogens which cause sub-optimum growth or death of the 
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fish and severe economic loss to aquaculture farmers.  To safeguard the health of fish and 
shell fish and reduce financial losses, aquaculture farmers are relying on the sub-therapeutic 
use of antibiotics such as chloramphenicol, sulfa drugs, ampicillin and fluoroquinolones.  
This management practice is short-sighted and irresponsible because such misuse of 
medically important antimicrobials in animal production selects for antibiotic-resistant 
Salmonella serovars (D’Aoust, 1994; D’Aoust et al., 1992).  This in turn can have severe 
health consequences when consumers eat pond-raised fish in a sushi meal or in a lightly 
cooked form, or shellfish, contaminated with antibiotic-resistant salmonellae (D’Aoust, 1994; 
D’Aoust et al., 1992). 
 In recent years fresh fruits and vegetables have emerged as vehicles of human 
salmonellosis (Harris et al., 2003).  Factors that contribute to that situation include increased 
imports of fresh and dehydrated vegetables from foreign countries that have a tropical 
climate year round.  Also, in those countries, hygienic conditions during crop production, 
harvesting, and distribution may not meet minimum U.S. standards thus facilitating microbial 
contamination of fresh produce.  More importantly, the fertilization of crops with untreated 
sewage or non-composted animal manure, irrigation of fields and washing of fresh produce 
with contaminated water, improper handling of produce by workers, and numerous other 
opportunities for environmental contamination of dried vegetables and spices during the 
drying process are factors that facilitate the accumulation of human enteric pathogens 
including Salmonella for which several reservoirs exist.  
 
Foodborne outbreaks 
The current increase in salmonellosis in the U.S. may be related to four factors: (1)  
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increased number of antimicrobial-resistant Salmonella isolates, (2) increased 
immunodeficient individuals, (3) increased egg-associated Salmonella Enteritidis 
contamination due to increased laying hens with infected ovaries, and (4) centralized food 
production that increase the risk of widespread distribution of contaminated food to cause 
large outbreaks (Tauxe, 1984).  Salmonella enterica serotype Typhimurium and Salmonella 
enterica serotype Enteritidis have been the most frequently reported causes of foodborne 
illnesses since 1993.  The Center for Disease Control and Prevention (CDC) 2011 Estimates 
of Foodborne Illness report linked to Salmonella are 1,027,561 illnesses, 19,336 
hospitalizations, and 378 deaths.  The twenty most common serotypes of Salmonella in 2006 
represented 70% of all Salmonella isolates. The four most common serotypes were 
Typhimurium, Enteritidis, Newport, and Heidelberg (45% of all isolates;CDC, 2008). There 
were 121 outbreaks in 2006, and more than 3,300 illnesses (Enteriditis (26), Typhimurium 
(26), Newport (10), and Heidelberg (10); CDC, 2006).  Raw or undercooked chicken and 
eggs are usually the foods thought to be most commonly associated with Salmonella; 
however, from 2006 to 2011, various serovars of Salmonella have been linked to 
contamination of the other foods including: tomatoes, banquet pot pies, dry pet food, peanut 
butter, cantaloupes, Malt-O-Meal Rice/wheat cereals, pistachios, alfalfa sprouts, red and 
black pepper, gourmet seasoning, soup/dip mixes, vegetable broth, granola bars, ceviche, 
potato chips, and eggs (http://www.cdc.gov/salmonella/outbreaks.html).  During 2004, a 
multistate outbreak of serotype Javiana infections associated with tomatoes at a gas station 
deli chain affected more than 400 people in 5 states (CDC, 2008).  Salmonella Tennessee 
was involved in a notable outbreak associated with peanut butter distributed worldwide, and 
caused over 700 cases of illness in 48 states (CDC, 2007a).  In 2006, two Salmonella 
 41 
 
(Newport and Typhimurium) outbreaks were associated with consumption of raw tomatoes 
in restaurants causing a total of 309 illnesses (CDC, 2007b).  In 2009 there was a multistate 
outbreak of Salmonella Typhimurium associated with peanut butter and peanut butter 
containing products resulting in 529 people infected in 43 states, 116 people hospitalized and 
8 deaths.  In August 2010, there were two recalls related to eggs contaminated with 
Salmonella Enteritidis from two farms located in Iowa.  Approximately 550 million eggs 
were recalled nationwide; more than 2000 people were sickened, between May 1, 2010 and 
Nov 30, 2010 (CDC, 2010).  Based on these previously mentioned outbreaks, salmonellosis 
continues to be a major food safety problem in the United States. Therefore, much greater 
attention needs to be paid to control the pathogen at all points in the food chain from farm to 
consumer. 
 
Characteristics of salmonellosis 
Salmonellosis in humans can cause serious ailments including enteric (typhoid) fever, 
enterocolitis, and systemic infections.  Typhoid and paratyphoid serovars of the pathogen are 
able to invade and survive in human intestinal cells and subsequently cause enteric fever, a 
serious human disease.  Symptoms of enteric fever occur after an incubation period of 7 to 28 
days and may include nausea, diarrhea, fever, abdominal pain, headache, and prostration 
(D’Aoust, 1991).  Disease diagnosis depends on isolation of the pathogen from the patient’s 
blood and urine in the initial stages of infection or from fecal material after the onset of 
symptoms (D’Aoust, 1989).  Following the acute phase involving enteric fever, the patient 
usually enters an asymptomatic chronic carrier state.  Antibiotics such as chloramphenicol, 
ampicillin, or trimethoprim-sulfamethoxazole are used to treat patients with enteric fever to 
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eliminate the systemic infection.  Within the past two decades marked global increases in 
antibiotic-resistant Salmonella have challenged the efficacy of antibiotic therapies.  This 
problem is further exacerbated in developing countries where outbreaks of enteric fever are 
frequently associated with salmonellae that exhibit multiple antibiotic resistance and cause 
unusually high mortality rates (Carmen Palomino et al., 1986; Rajajee et al., 1995).   
Salmonellosis caused by non-typhoid Salmonella serovars usually results in 
enterocolitis and abdominal pain although systemic infections may occur in some instances.  
The pathogen invades the mucosa of the small intestine, proliferates in the epithelial cells, 
produces a toxin and causes inflammation.  After invasion of the epithelial cells it multiplies 
and produces an enterotoxin.  Symptoms may appear in 6 to 48 hours after ingestion of 
contaminated food or water.  Acute symptoms include nausea, vomiting, abdominal cramps, 
non-bloody diarrhea, chills, fever, headache and prostration lasting 2 to 3 days or more.  
Generally, the disease is self-limiting and regression of diarrhea and abdominal pain occurs 
within 5 days after the onset of symptoms (D’Aoust, 1989).  Although it was previously 
thought that relatively large amounts of the pathogen had to be ingested to cause disease, the 
infectious dose of Salmonella can be relatively small (15-20 cells) depending on the serotype. 
Chronic symptoms include enlargement of the liver and spleen, infection of tissues 
surrounding the brain and spinal cord, and reactive arthritis (Mayo Clinic, 2009, April 
17).  Salmonellosis can be fatal to elderly, infants and immune compromised individuals.  
 
 
 
Staphylococcus aureus 
Morphology and characteristics  
The etymological root of the bacterium’s name: staphylo (bunch of grapes) is derived  
 43 
 
from Greek and aureus (golden) is derived from Latin.  The organism’s name pertains to the 
gold colonies that are formed on agar medium.  Staphylococcus aureus is gram-positive, non-
spore forming, non motile, spherical cells (0.5 to 1 µm) occurring singly, in pairs, or in 
grape-like clusters.  The main habitat of this mesophilic, facultative anaerobe is on human 
skin, mouth or nose, and animal hides, feathers, and skin.  The genus Staphylococcus belongs 
to the bacterial family Staphylococcaceae.  More than 20 species of Staphylococcus, some 
pathogenic and some non-pathogenic, have been delineated by DNA hybridization (Kloos 
and Schleifer, 1986; Freney et al., 1988).  Several Staphylococcus species
 
have been 
implicated in human infections, notably S. aureus, S. saprophyticus,
 
S. epidermidis, S. 
lugdunensis, and S. schleiferi (Tenover and Gayne 2000; von Eiff et al., 2002; Choi et al., 
2006; Otto, 2009).  Many strains are known to be enterotoxin producers; however, their 
involvement as foodborne pathogens is unknown (Becker et al., 2001).  S. aureus is the most 
common strain associated with human foodborne illness.  
Staphylococcus aureus strains can be classified into the following 6 biotypes 
according to their human or animal origin: a) human, b) non-β-hemolytic human, c) avian, d) 
bovine, e) ovine, and f) nonspecific (Devriese, 1984).  Generally, S. aureus strains produce at 
least 34 different extracellular enzymes, toxins, and other chemical components; however, 
strain differences occur and no one strain is capable of producing all of these proteins 
(Landolo, 1989).  Nearly all strains of S. aureus produce the enzymes coagulase, 
thermonuclease, and hemolysin and are also resistant to digestive proteolytic enzymes, such 
as trypsin and pepsin (Le Loir et al., 2003).  There are two groups of heat stable enterotoxins 
produced by S. aureus, Group 1: A, B, C1, C2, C3, D, and E; Group 2: G, H, I, J, K, L, M, N, 
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O, P, Q, R, and U (Dinges et al., 2000; Jarraud et al., 2001; Baba et al., 2002; Omoe et al., 
2002).  
Several factors influence enterotoxin production in foods and the extent to which the 
toxin may cause foodborne illness.  Factors include numbers of viable S. aureus in the food, 
type and composition of food, holding temperature, amount of food consumed, presence of 
inhibitors, health of the consumer, susceptibility to the toxin, and type of toxin produced 
(Doyle et al., 1997).   Rate of toxin production by a strain is directly related to its rate of 
growth and cell concentrations.  Viable cells of S. aureus at a level greater than 10
5
 or 10
6
 per 
gram of food have been associated with enterotoxin production at concentrations sufficient to 
cause disease even though lower viable numbers of the pathogen have at times been 
implicated in causing foodborne disease.  Enterotoxin concentrations ranging from 1- 5 µg 
have been demonstrated in foods involved in many S. aureus food poisoning outbreaks; 
however, enterotoxin doses as little as 10 nanograms or less can cause food poisoning (Doyle 
et al., 1997). 
Growth temperature of S. aureus ranges from 7 to 47.8 °C and optimal growth 
temperature range is 30 – 35 °C (Schmitt et al., 1990).  Cells can be killed by heating at 66 
°C for 12 minutes and at 72 °C for 15 seconds.  The pH range for growth of the pathogen is 
4.5 to 9.3 (Scott, 1953) whereas, the optimum pH for growth is between 7.0 and 7.5 
(Bergdoll, 1989; Martin and Myers, 1994).  S. aureus is highly tolerant to salt (up to 10%) 
and sugars and can grow within a water activity (aW) range 0.83-0.99.  Although the 
pathogen may grow at aW as low as 0.83, a minimum aw of 0.86 is required for enterotoxin 
production (Lund, 2000).  The ability of S. aureus to grow at 6–7 °C, low pH, and low water 
activity levels depends on other intrinsic or extrinsic factors being optimal for the pathogen 
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(Jay, 1992). Ability to grow under several adverse conditions allows the pathogen to multiply 
without intense competition from normal microflora present in food.  Eradication of 
staphylococci is not always successful due to their ability to form biofilms (Nostro 2007). 
Staphylococcus aureus strains are frequently involved in foodborne intoxications.  
 
Reservoirs 
 Humans and animals are important reservoirs of S. aureus.  This pathogen and other 
staphylococci can be found on skin and skin glands of humans, other mammals and birds.  It 
has been isolated from nostrils, mouth, upper respiratory tract, mammary glands, intestinal 
tract and genitourinary tract of infested hosts (Murray et al., 1999).  The anterior part of the 
nasal passages is a well-known site for colonization of S. aureus, although the pathogen can 
be found on the skin.  It is estimated that about 50% of healthy humans naturally carry S. 
aureus as part of their normal microflora (Jay et al., 2005).  Contamination of food with this 
pathogen can occur by direct contact of food with contaminated hands of workers.  Also, 
food contamination may occur indirectly from shed skin cells or aerosols generated from 
coughing and or sneezing, which expel droplets from the respiratory tract.  The majority of 
sources of staphylococcal food poisoning have been traced to humans who contaminated 
foods during preparation or improper handling following preparation.  Generally, animals 
may harbor very high populations of S. aureus (Jay et al., 2005).  Colonization of animals 
with this human enteric pathogen is of major public health concern because of the potential 
for contamination of foods of animal origin before or during processing.  Other sources for 
transfer of the pathogen to food include equipment and materials used in food processing 
such as improperly cleaned and sanitized meat grinders, saws blades, knives, cutting boards, 
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and food storage containers.  Apart from being on the human body or on food processing 
implements, S. aureus can persist for extended periods of time in a desiccated state.  This 
pathogen is one of the most resistant non-spore-forming pathogens and has been isolated 
from air, dust, water and sewage (Doyle et al., 1997). 
 
Foodborne outbreaks 
The growth and proliferation of S. aureus in foods presents a potential hazard to 
consumer health since many strains of S. aureus produce enterotoxins.  The association of 
staphylococci with foodborne illness dates back as early as 1884, when a large food 
poisoning outbreak in the U.S. was linked to contaminated cheese.  In 1989 the consumption 
of canned mushrooms contaminated with S. aureus enterotoxin A, caused multiple 
staphylococcal foodborne outbreaks (Feb. 13, Feb. 28, and April 17; Hard-English et al., 
1990). These outbreaks led to 82 sick individuals, and of those 12 were hospitalized. 
Between 1993 and 1997, 42 outbreaks occurred, involving 1,413 cases, and one death (CDC, 
2002).  Based on the Center for Disease Control and Prevention (CDC) 2011 Estimates of 
Foodborne Illness for 2011, approximately 241,148 illnesses will be associated with S. 
aureus.  Foods commonly associated with staphylococcal food poisoning include meat and 
meat products, fish, eggs, fruits and vegetables (mashed potatoes), salads, cream-filled 
bakery products, dry pasta and dairy products (Bean and Griffin, 1987; Evenson et al., 1988; 
Bean et al., 1990; Ray, 2005).  Many of these items are contaminated post processing, during 
food preparation in homes, food service establishments, or mishandling prior to consumption 
(temperature abuse, poor hygiene).  Human intoxication is caused by ingesting enterotoxins 
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produced in food, usually because of temperature abused food (hot holding temperature 
below 60°C or cold holding temperature above 4 °C). 
 
Characteristics of Staphylococcus aureus intoxication 
Staphylococcal food poisoning (staphylococcal gastroenteritis) is a self-limiting 
illness due to the absorption of staphylococcal enterotoxins preformed in the food (Le Loir et 
al., 2003).  Generally, a toxin level that results in human illness is reached when S. aureus 
populations exceed 10
6
 colony forming units.  The infectious dose varies and a healthy adult 
must consume 30 g or ml of food containing 100 to 200 ng toxins to experience illness 
whereas, lower amounts of the toxin have caused illness in immune-compromised individuals 
(Bergdoll, 1990; Ray, 2005).  Severity of symptoms is directly related to an individual’s 
susceptibility, general health, potency and amount of toxin ingested. The onset of symptoms 
can occur anywhere from 30 min to 8 hours (2 - 6 hours average) after consumption of 
contaminated food containing preformed toxin (Dack, 1956).  Primary symptoms are 
abdominal cramps, nausea, vomiting, occasionally followed by diarrhea (never diarrhea 
alone) and prostration.  Secondary symptoms include dehydration, headache, chills, fever, 
transient changes in blood pressure and pulse rate. Recovery typically takes 2 days.  More 
serious symptoms include toxic shock syndrome (release of super antigens into the blood 
stream), pneumonia, mastitis, phlebitis, meningitis, urinary tract infections, osteomyelitis and 
endocarditis. Death related to staphyloccal food poisoning is very rare.  For the general 
public the fatality rate is about 0.03%; however, this rate increases to about 4.4% for more 
susceptible groups such as young children and the elderly (Holmberg and Blake, 1984). 
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Abstract 
The antibacterial effect of phosvitin or carvacrol alone or combined, against Salmonella 
enterica and Listeria monocytogenes in brain heart infusion (BHI) broth and onion 
mushroom soup was investigated.  Broth with added phosvitin (10, 20, 40, 60, 80 or 100 
mg/ml), or carvacrol (0.09, 0.12, 0.14, 0.19, 0.38, or 0.75 mg/ml) was inoculated with S. 
enterica or L. monocytogenes to a final concentration of 5.0 log CFU/ml per pathogen.  Broth 
or soup without antimicrobials served as control.  Growth of S. enterica and L. 
monocytogenes in BHI (35 °C, 24 hours) was monitored using a Bioscreen C turbidometer 
(OD 600nm).  Growth of the pathogens in soup (12 °C, 8 days) and (35 °C, 24 hours) was 
monitored by surface plating samples.  In BHI broth the minimum inhibitory concentration 
(MIC) of phosvitin and carvacrol was 80 mg/ml and 0.14 mg/ml, respectively, for both S. 
enterica and L. monocytogenes.  In soup (12 °C) all antimicrobial treatments tested decreased 
viable counts of both pathogens after 2 days of storage.  In control soup viable numbers 
increased to 6.95 and 8.72 log CFU/ml at day 8 for S. enterica and L. monocytogenes, 
respectively.  In soup (35 °C) viable counts of the pathogens were decreased by the higher 
concentration of carvacrol (0.40 mg/ml) and phosvitin (60 mg/ml) plus carvacrol 
concentrations (0.20 or 0.40 mg/ml).  The combination of phosvitin (60 mg/ml) and carvacrol 
(0.40 mg/ml) exerted the greatest cidal effect throughout storage against S. enterica and L. 
monocytogenes.    
Introduction 
The growing number of foodborne illness-related outbreaks due to human enteric pathogens 
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is an increasing concern to regulatory agencies, the food industry, and consumers.  While 
effective control of foodborne pathogens is crucial to ensuring microbial food safety, 
methods of control involving synthetic chemical preservatives are becoming less desirable to 
consumers.  This consumer attitude is part of a growing trend towards “Green Consumerism” 
emphasizing the reduction or elimination of preservative agents such as nitrite and sodium 
chloride from foods (5) and encouraging the use of natural antimicrobials from animal, plant 
or microbial sources to preserve foods, promote healthier foods and improve food safety.  
Phosvitin is a 35 kDa glycoprotein found exclusively in the granule fraction of 
chicken egg yolk, making up 7% of the yolk protein and 80% of the protein bound 
phosphorus (39, 49). This 217 amino acid peptide is composed of over 50% serine residues, 
of which 90% are phosphorylated (6, 7, 41).  Phosvitin contains between 3 to 6 iron atoms 
per molecule depending on the method of isolation from hens’ eggs; however, it has a 
binding capacity of about 60 iron molecules (2, 26, 40, 51).  Phosvitin is a strong metal 
chelator and could be used as an antimicrobial agent.  To date there is only one published 
report demonstrating the antibacterial activity of phosvitin (37).  Researchers found that the 
combination of phosvitin and thermal stress (50 °C) was bactericidal against Escherichia 
coli.  It is likely that phosvitin sensitized this organism to the lethal effects of heat in a 
laboratory broth  medium.        
Herbs and spices have been used for centuries specifically for medicinal purposes, 
flavor, fragrances, and as natural preservative methods for a variety of foods (1, 8).  The 
majority of essential oils are classified as Generally Recognized As Safe (GRAS).  The 
phenolic compounds in the essential oil fraction of the plant possess antimicrobial properties 
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(4). Carvacrol is an essential oil found in the leaves and flowering plant of both thyme 
(Thymus vulgaris) and oregano (Origanum vulgare) (5, 31).  The percent composition of 
carvacrol in oregano ranges from trace amounts to 82% and 2 to 45% in thyme (3, 5, 23).  
The hydrophobic phenolic compound in its structure is thought to be the main contributor to 
its antimicrobial properties (47).  Several studies have demonstrated that carvacrol has both 
bacteriostatic and bactericidal activity against microorganisms including: Listeria 
monocytogenes (10, 12, 17, 31, 33, 34, 35, 38, 48), Bacillus cereus (35, 42-47),  Escherichia 
coli  O157:H7 (10-12, 14, 16, 29, 31-33, 52), Staphylococcus aureus (20, 24, 31), and 
Salmonella enterica  (11, 14, 20, 22, 28, 36, 53).  Carvacrol has been shown to possess 
stronger antimicrobial effect with increased temperature and storage time, and at a lower pH 
(5, 11).  
The antimicrobial properties of both of these natural antimicrobials may be used to 
improve microbial safety of foods, with combined use possibly increasing the effectiveness 
of the antimicrobial treatments against foodborne pathogens.  Also, synergy between two of 
these antimicrobials may permit the use of relatively lower amounts of each antimicrobial 
and thereby reducing cost of the antimicrobial treatment.  While there is a growing body of 
knowledge on the antimicrobial effects of carvacrol against various foodborne pathogens, 
such published research involving phosvitin is scarce.  To our knowledge there is no 
published research involving the combined use of phosvitin and carvacrol against Salmonella 
enterica and Listeria monocytogenes.  Accordingly the objective of the present study was to 
evaluate the antimicrobial efficacy of phosvitin, carvacrol and their combinations in onion 
mushroom soup held at 12 °C or 35 °C. 
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Materials and Methods 
Bacterial cultures and culture conditions. Five strains of Listeria monocytogenes 
(H7962-4b, H7762-4b, H7596-non4b, H7969-4b, and NADC-2045-4b) and five serotypes of 
Salmonella enterica (Enteritidis-ATCC13076, Heidelberg, Typhimurium-ATCC 14802, 
Gaminara-8324, Oranienburg-9329) were obtained from the culture collection of the 
Microbial Food Safety Laboratory, Iowa State University, Ames, IA.  Stock cultures were 
kept frozen (-70 ºC) in Brain Heart Infusion (BHI) broth (Difco, Becton, Dickinson, Sparks, 
MD) supplemented with 10% (vol/vol) glycerol.  Stock cultures were activated in BHI broth 
(pH 7.2) and incubated at 35 °C.  At least two consecutive 18 to 22-h transfers of each stock 
culture were carried out before using the cells as inocula in each experiment. 
 Preparation of Inoculum.  An equal volume of the individual working cultures of L. 
monocytogenes or S. enterica were combined in a sterile centrifuge tube.  The cells were 
harvested by centrifugation (10,000 x g, 10 min, 4 °C) using a Sorvall Super T21 (American 
Laboratory Trading, Inc., East Lyme, CT) and washed once in 0.1% (wt/vol) peptone.  The 
pelleted cells were suspended in fresh 0.1% (wt/vol) peptone to obtain a final viable cell 
concentration of approximately 10
9
 CFU ml
-1
.  Viable counts of the washed cell suspensions 
were evaluated by surface plating serially diluted (10-fold) samples on tryptic soy agar 
supplemented with 0.6% yeast extract.  The individual cell suspensions were used to 
inoculate BHI broth or commercial onion mushroom soup.  
Antimicrobials.  Phosvitin was supplied by Dr. Dong Ahn from the Department of 
Animal Science at Iowa State University, Ames, IA.  A commercial preparation of carvacrol 
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was purchased from Sigma-Aldrich (Aldrich W224502).  
Total phenolic content of carvacrol.  The concentration of total phenolics of 
carvacrol was determined using the method described by Waterman and Mole (50). The 
assay involves reduction of ferric iron to the ferrous state by phenolic compounds that results 
in the formation of the Prussian blue complex Fe4[Fe(CN)6]3 with a potassium ferricyanide 
reagent.  The Prussian blue complex was determined colorimetrically (18).  Two separate 1% 
(vol/vol) solutions of carvacrol in 10% (vol/vol) ethanol and deionized water were prepared. 
The absorbance of three sub-samples from each solution was measured at 720 nm and the 
total phenolic content expressed as the number of catechin equivalents x 100.  
Preparation of treatment solutions for Bioscreen C Assay.  BHI broth with added 
phosvitin (10, 20, 40, 60, 80, 100 mg/ml) or carvacrol (0.09, 0.12, 0.14, 0.19, 0.38, or 0.75 
mg/ml) was filter sterilized using 0.22 µm pore size Millipore filters (Fisher Scientific, 
Pittsburgh, PA).  Samples (2.5-ml) of the treatment solutions and control (BHI with no added 
antimicrobial) were each inoculated with 25 µl of diluted (1:100) L. monocytogenes or S. 
enterica cell suspension to obtain a final concentration of approximately 10
5
 CFU/ml of 
sample. 
Bioscreen C assay.  Aliquots (200-µl) of inoculated samples were added in triplicate 
to the wells of microtiter plate for the Bioscreen C Turbidometer (Growth Curves, 
Piscataway, NJ), an automated microbial growth analyzer and incubator.  Plates were 
incubated in the Bioscreen C at 35 °C for 24 h and the instrument was programmed to record 
optical density (OD) measurements at 600 nm every 30 min, with shaking of samples before 
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each OD reading. Minimum inhibitory concentration (MIC) was defined as the lowest 
treatment concentration that completely inhibited microbial growth for 24 hr (< 0.05 OD unit 
increase).  
Preparation and inoculation of soup.  Dehydrated onion mushroom soup/dip mix 
was purchased from a local grocery store.  The soup mix was hydrated with sterile distilled 
water and prepared according to the directions stated on the package.  Soup ingredients are 
shown in Table 1.  After boiling, the soup was tempered to ~ 35 °C and 10-ml portions of the 
soup were aseptically transferred into sterile 30 ml screw cap Pyrex tubes.  Phosvitin, 
carvacrol or combinations were added to each tube to yield the following concentrations: 
phosvitin (60 mg/ml), carvacrol (0.20 mg/ml or 0.40 mg/ml), phosvitin (60 mg/ml) + 
carvacrol (0.20 mg/ml) and phosvitin (60 mg/ml) + carvacrol (0.40 mg/ml).   Phosvitin was 
added to the tube prior to the addition of the soup to prevent aggregation and facilitate its 
dissolving in the soup.  Tubes of soup without added antimicrobial served as control.  The 
treatments were then warmed or cooled to the target temperature.  Tubes of soup with added 
antimicrobials were mixed by vortexing and inoculated with a suspension of washed cells of  
S. enterica or L. monocytgenes to generate a final cell concentration of approximately 10
5
 
CFU/ml for each pathogen.  After inoculation, each tube of soup was gently mixed by 
vortexing and held at either 12 °C or 35 °C.  
Microbiological analysis.  Inoculated tubes, of soup held at 12 °C, were tested for 
survivors of the pathogens every 2 days for a total of 8 days whereas, soup, held at 35 °C, 
were tested at 4, 8, 12 and 24 h.  Ten-fold serial dilutions of the soup were prepared using 
0.1% (wt vol/vol) peptone with added Tween 80.  Aliquots (1.0 ml or 0.1ml) of the soup or 
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diluted samples of soup were surface plated (in duplicate) on xylose lysine desoxycolate 
(XLD) agar (for S. enterica) and modified oxford medium (for L. monocytogenes).  All 
inoculated plates were incubated at 35 °C for 48h before counting bacterial colonies.  
Measurement of pH and water activity.  Measurements of pH were taken using an  
an Orion Model 525 pH meter (Orion Research, Inc., Boston, Massachusetts) fitted with a 
glass electrode.  Water activity measurements were made using the Aqualab CX2 water 
activity meter (Decagon Services, Pullman, Washington).  The initial pH and water activity 
of each sample of soup, including controls, was measured at day 0 (prior to inoculation).  
Measurements of pH were also taken periodically during storage of the soup at 12 °C or 35 
°C. 
Statistical analysis. Three independent replications of each experiment were 
performed.  Mean numbers of viable L.  monocytogenes or S. enterica were statistically 
analyzed using SAS statistical software version 8.1 (SAS Institute Inc., Cary, N.C.).  
Treatment means were evaluated for statistically significant differences using Tukey’s test.  
Significant differences were defined at P < 0.05 for all the experimental data. 
Results 
Inhibitory effect of phosvitin in BHI broth.  Figures 1 and 2 show the effect of 
various evels of phosvitin on the growth of Salmonella enterica and Listeria monocytogenes, 
respectively, in Brain Heart Infusion (BHI) broth at 35 ºC.  For S. enterica the optical density 
(OD) of control and BHI broth containing 10 mg/ml phosvitin increased rapidly and reached 
OD greater than 1.2 within 18 hours.  Growth inhibition of S. enterica markedly increased 
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with higher phosvitin concentrations.  Compared to control and 10 mg/ml, all concentrations 
of phosvitin extended the lag phase of the pathogen.  Phosvitin concentrations of 80 and 100 
mg/ml were bacteriostatic.  The minimum inhibitory concentration (MIC) of phosvitin for S. 
enterica was 80 mg/ml.   
Growth of L. monocytogenes increased rapidly in control broth; the OD of the culture 
increased from 0.1 (at 7h) to greater than 0.6 (at 18h).  As observed with Salmonella all 
phosvitin concentrations inhibited growth of L. monocytogenes with higher concentrations 
causing greater growth inhibition.  Greater extensions of the lag phase were observed with 
increased phosvitin concentrations.  Phosvitin at 80 and 100 mg/ml was bacteriostatic to L. 
monocytogenes and the MIC of phosvitin for this pathogen was also 80 mg/ml.   
Inhibitory effect of carvacrol in BHI broth.  Growth of S. enterica and L. 
monocytogenes in BHI supplemented with various concentrations of carvacrol is shown in 
Figures 3 and 4, respectively.  For S. enterica the OD of control increased from 0.1 to greater 
than 1.0 within 16 hours.  Of all carvacrol concentrations tested, increases in OD were only 
observed in cultures with the two lowest concentrations (0.09 and 0.12 mg/ml).  At 24 hours 
the OD values of control, and BHI broth with 0.09 mg/ml and 0.12 mg/ml were 1.03, 0.68 
and 0.39, respectively.  All other concentrations (0.14 to 0.75 mg/ml) of carvacrol completely 
inhibited growth of S. enterica.  The MIC of carvacrol for S. enterica was 0.14 mg/ml.  
Except for 0.09 and 0.12 mg/ml, all other carvacrol concentrations tested completely 
prevented an increase in OD of L. monocytogenes cultures.  Broth with 0.09 mg/ml had little 
or no effect on the growth of this pathogen; increases in OD were very similar to that of the 
control.  The MIC of carvacrol for L. monocytogenes was 0.14 mg/ml. 
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Antibacterial effect of phosvitin and carvacrol in soup at 12 ºC.  The total 
phenolic content of the 1% solution of carvacrol was 0.98 catechin equivalents.  This result 
coincides with the manufacturer’s claim of “up to 98% total polyphenols”.  The initial pH of 
the soup was 6.1 and water activity 0.994.  Tables 2 and 3 show viable counts of S. enterica 
and L. monocytogenes, respectively, in onion mushroom soup (12 °C) with phosvitin, 
carvacrol, or combinations of those antimicrobials.  The initial viable count of S. enterica or 
L. monocytogenes in soup was ~ 10
5
 CFU/ml.  For both pathogens the initial viable counts in 
control soup declined slightly after two days of storage; 0.38- and 0.40- log decreases were 
observed for S. enterica and L. monocytogenes, respectively.  All antimicrobial treatments 
tested decreased viable counts of both pathogens after two days of storage.   
In control soup viable counts of S. enterica increased from 4.60 log CFU/ml (day 2) 
to 6.95 log CFU/ml at day 8 (Table 2).  Phosvitin (60 mg/ml) or carvacrol (0.20 or 0.40 
mg/ml) inhibited growth of this pathogen; viable counts (log CFU/ml) at day 8 of storage 
were 5.28, 4.99, and 2.27 respectively, in soup containing phosvitin (60 mg/ml), carvacrol 
(0.20 mg/ml) and carvacrol (0.40 mg/ml).  The combination of phosvitin (60 mg/ml) and 
carvacrol (0.40 mg/ml) exerted the greatest cidal effect against S. enterica at day 2; viable 
counts were decreased by 3.91 log.   From day 4 through day 8 viable counts of the pathogen 
were undetected (< 10 CFU/ml); however, results of enrichment tests performed on the soup 
samples were positive for the pathogen (data not shown).    
Viable numbers of L. monocytogenes increased from 4.62 log CFU/ml (day 2) to 8.72 
log CFU/ml at day 8 in control soup.  In soup that contained phosvitin (60 mg/ml) initial 
numbers of the pathogen were decreased by 1.05 log at day 2 and survivors increased slowly 
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to reach 5.37 log CFU/ml at day 8.  Carvacrol at 0.20 mg/ml reduced initial counts of L. 
monocytogenes by 1.1 log CFU/ml; however, survivors grew relatively fast and reached 
counts of 8.81 log CFU/ml at day 8.  Viable counts (log CFU/ml) at day 8 for the remaining 
4 treatments were 4.77 (0.40 mg/ml carvacrol), 4.38 (60 mg/ml phosvitin + 0.20 mg/ml 
carvacrol), and 3.17 (60 mg/ml phosvitin + 0.40 mg/ml carvacrol).   
Antibacterial effect of phosvitin and carvacrol in soup at 35 ºC.  Log reduction in 
the initial viable count of S. enterica following 4 hours of exposure to antimicrobials in onion 
mushroom soup at 35 ºC is shown in Figure 5.  The pathogen grew in control soup and in 
soup with added phosvitin (60 mg/ml) or the lower concentration of carvacrol (0.20 mg/ml).   
Soup with carvacrol (0.40 mg/ml), 60 mg/ml phosvitin + 0.20 mg/ml carvacrol), or 60 mg/ml 
phosvitin + 0.40 mg/ml carvacrol exhibited a cidal effect on the pathogen; initial viable 
counts (control 7.63 log CFU/ml) were reduced by 5.48, 4.48, and 7.33, respectively 
(P<0.05).   
Tables 4 and 5 show the viability of S. enterica and L. monocytogenes respectively, in 
onion mushroom soup (35 °C) with added phosvitin (60 mg/ml), carvacrol (0.20 or 0.40 
mg/ml) or their combinations.  In control soup viable numbers of S. enterica increased from 
7.63 log CFU/ml at 4 hours to 11.31 log CFU/ml at 24 hours.  Compared to control, 
phosvitin significantly inhibited growth of the pathogen up to 12 hours at 35 ºC (P<0.05).  Of 
the two concentrations of carvacrol tested the lower one (0.20 mg/ml) did not significantly 
inhibit growth of the pathogen in the soup for 24 hours (P>0.05).  In fact, viable counts (log 
CFU/ml) of the pathogen in soup with 0.20 mg/ml carvacrol increased from 6.39 at 4 hours 
to 10.14 in 24 hours (Table 4).  However, when 0.20 mg/ml carvacrol was used in 
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combination with phosvitin, a much stronger inhibitory effect against the pathogen was 
observed compared to that produced by phosvitin or carvacrol (0.20 mg/ml) used singly 
(P<0.05).  The extent of growth inhibition produced by that combination of phosvitin and 
carvacrol was similar to that observed with the higher concentration of carvacrol (0.40 
mg/ml).  Phosvitin combined with 0.40 mg/ml carvacrol exhibited the greatest cidal effect 
against S. enterica (P<0.05); no viable counts of the pathogen could be detected in the soup 
from 8 to 24 hours (Table 4).  In all instances when no viable counts were detected by 
plating, enrichment tests gave positive results for presence of the pathogen (data not shown). 
Viable numbers of L. monocytogenes in control soup increased from 4.60 log CFU/ml 
at 4 hours to 8.01 log CFU/ml at 24 hours (Table 5).  Phosvitin suppressed the growth of L. 
monocytogenes throughout the duration of the study and its inhibitory effect was significantly 
greater from that of the control from 8 to 24 hours (P<0.05).  Compared to control, carvacrol 
(0.20 mg/ml) alone did not significantly inhibit growth of L. monocytogenes (P>0.05).  The 
higher concentration of carvacrol (0.40 mg/ml) and both phosvitin/carvacrol combinations 
tested significantly inhibited growth of the pathogen from 8 to 24 hours (P<0.05). 
 Phosvitin plus carvacrol (0.20 mg/ml) was able to suppress growth of the pathogen 
until 24 hours of incubation.  The combination of phosvitin and carvacrol (0.40 mg/ml) was 
significantly different from the control after 4 hours.  This combination caused a decline in 
viability of the pathogen in the soup at 35 °C which is highly conducive to prolific growth of 
the pathogen throughout storage.   
Discussion 
The application of naturally derived antimicrobials in foods is gaining increasing  
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attention from the food industry as consumers become concerned over possible negative 
health effects from long-term consumption of synthetic food preservatives.  Certain 
naturally-derived organic compounds have good potential for use in inhibiting microbial 
growth or destroying foodborne organisms to extend the microbial shelf-life of foods (27).  
Based on the results of the present study of phosvitin used alone or combined with carvacrol 
to control foodborne pathogens in a food product offers further evidence on the antibacterial 
potential of these compounds.   
While there is a growing body of knowledge on the antimicrobial effects of carvacrol, 
there is a scarcity of published reports on the antimicrobial effects of phosvitin.  Also, there 
are no published reports on the combined antibacterial effectiveness of phosvitin and 
carvacrol against foodborne human enteric pathogens.  In the present study phosvitin 
strongly inhibited growth of both S. enterica and L. monocytogenes in BHI broth at 35 °C 
(Figures 1 and 2).  Plate counts to determine numbers of viable pathogens in BHI with 
phosvitin at the minimum inhibitory concentration (MIC) for each organism (80 mg/ml) 
revealed that phosvitin exerted a bacteriostatic effect on both pathogens (data not shown).  
This observed inhibition is likely due to phosvitin binding divalent metal ions such as iron 
(30) which is an essential mineral for microbial growth (15).  Approximately ninety-five 
percent of iron in hen’s egg yolk is strongly bound by phosvitin in a stable conformation to 
avoid being used by microbes (13).  Such iron ligation can result in suppression of microbial 
growth in the hen’s egg to protect the developing chick embryo from microbial attack. 
Compared to phosvitin, carvacrol completely inhibited growth of S. enterica and L. 
monocytogenes at a far lower concentration (MIC = 0.014 mg/ml) (Figs 3 and 4).  Plate 
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counts on cultures of the pathogens in BHI broth with MIC of carvacrol revealed that this 
antimicrobial was bactericidal; viable numbers of both pathogens decreased over time (data 
not shown).  The antibacterial effectiveness of carvacrol against S. enterica and L. 
monocytogenes has been previously reported (17, 35, 36, 53).  The MIC of carvacrol 
observed for S. enterica in the present study is within the same range reported in previous 
studies (28) although higher MICs have been reported (5).  Variations in MICs may be 
attributed to variables such as strain of the organisms tested, type of growth medium and 
temperature, and potency of the antimicrobial. 
The main focus of this study was to determine the antimicrobial activity of phosvitin 
combined with carvacrol against S. enterica and L. monocytogenes in an actual food system 
namely, onion mushroom soup.  Considering the fact that improper temperature control can 
compromise the microbial safety of foods we intentionally held the soup at two abusive 
temperatures (12 ºC and 35 ºC).  At those temperatures the antimicrobial efficacy of 
phosvitin alone or combined with carvacrol was evaluated.  Holding soup at 12 °C simulates 
possible temperature conditions in a defective refrigerator that fails to maintain safe 
temperatures (< 4.4 °C).  Holding the soup at 35 °C simulates improper temperature control 
during hot holding especially if there is a failure of hot holding equipment to maintain 
temperatures at 60 ºC or higher.  Also, 35 ºC is within the optimum growth range of both 
pathogens.  Both Salmonella and Listeria grew very well in soup at 12 °C (Tables 2 and 3) 
and at 35 °C (Tables 4 and 5) indicating the potential of this food product to cause foodborne 
illness although it contains onion powder and garlic powder on the label (Table 1).  Both 
onion and garlic are known to contain antimicrobials including allicin (27); however, it is 
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likely that the amount of allicin in the soup is at miniscule levels because both onion powder 
and garlic powder are minor ingredients as shown on the label (Table 1). 
Based on the FDA Food Code potentially hazardous foods should not be held for 
more than four hours between 4.4 ºC and 60 °C (9).  In that temperature range called the 
“temperature danger zone”, foodborne pathogens can multiply rapidly.  For example, in the 
present study S. enterica reached 7.63 log CFU/ml of soup within 4 hours in soup held at 35 
ºC (Table 4).  This relatively rapid growth in onion mushroom soup represented 
approximately 2.63 log increase from the initial population (log 5.0 CFU/ml) of this 
pathogen.  A recent recall of onion soup/dip mix because of contamination with Salmonella 
(17) reinforces the need for antimicrobial interventions to ensure the microbial safety of these 
potentially hazardous products.  
The observed variability in antimicrobial effectiveness of phosvitin or carvacrol used 
singly in soup reinforces the fact that combined use of antimicrobials offers a more effective 
approach for controlling pathogens in foods (25).  In this regard the best and most reliable 
antimicrobial treatment was a combination of phosvitin (60 mg/ml) and carvacrol (0.40 
mg/ml) which maintained consistent control of both pathogens irrespective of temperature.  
The results of this study further emphasize the potential of using phosvitin in combination 
with other naturally derived antimicrobials to enhance its efficacy in controlling foodborne 
pathogens.  The antimicrobial effectiveness observed from the combined use of phosvitin and 
carvacrol could allow the use of lower concentrations of each antimicrobial for improved 
food preservation.  However, it is well accepted that the practical application of such 
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preservative systems would require further research on their impact on the sensory properties 
of foods. 
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TABLE 1. 
a
Ingredients in dehydrated onion and mushroom soup/dip mix. 
Cornstarch  
Dehydrated onions  
Salt  
Monosodium glutamate  
Maltodextrin  
Wheat flour  
Dehydrated mushrooms  
Partially hydrogenated soybean oil  
Hydrolyzed protein (corn, soy, wheat)  
Autolyzed yeast extract  
Caramel color  
Onion powder  
Guar gum  
Garlic powder  
Natural flavors  
Disodium guanylate  
Disodium inosinate  
*Sodium 700 mg- 29% 
a
 Ingredients are listed in the same order as they appear on the label of the package 
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FIGURE 1. Growth of Salmonella enterica in BHI broth (35 °C) supplemented with 
various concentrations of phosvitin. 
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FIGURE 2. Growth of Listeria monocytogenes in BHI broth (35 °C) supplemented 
with various concentrations of phosvitin. 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 2 4 6 8 10 12 14 16 18 20 22 24
O
p
ti
ca
l 
D
en
si
ty
 (
6
0
0
 n
m
)
Time (hours)
Control
10 mg/ml
20 mg/ml
40 mg/ml
60 mg/ml
80 mg/ml
100 mg/ml
 95 
 
 
FIGURE 3. Growth of Salmonella enterica in BHI broth (35 °C) supplemented with 
various concentrations of carvacrol. 
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FIGURE 4. Growth of Listeria monocytogenes in BHI broth (35 °C) supplemented with 
various concentrations of carvacrol. 
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FIGURE 5. Log reduction in initial count of Salmonella enterica following 4 hr of 
exposure to antimicrobials in onion mushroom soup at 35 °C. 
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TABLE 2.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Salmonella enterica in onion mushroom soup held at 12 ºC for 8 days. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
2d 4d 6d 8d 
 
Control 4.60 ± 0.05ax 6.26 ± 2.51ax 6.02 ± 3.44ax 6.95 ± 3.62ax 
 
Phosvitin (60) 4.42 ± 0.34ax 4.53 ± 0.14abx 4.49 ± 0.42ax 5.28 ± 1.59ax 
 
Carvacrol (0.20) 3.81 ± 0.20abx 5.24 ± 2.52abx 4.36 ± 3.86ax 4.99 ± 3.39ax 
 
Carvacrol (0.40) 1.38 ± 2.40bcx 1.75 ± 3.03abx 2.21 ± 3.83ax 2.27 ± 3.93ax 
 
Phos + Car (0.20) 
 
2.75 ± 0.75abcx 
 
2.36 ± 0.32abx 
 
2.49 ± 0.28ax 
 
1.90 ± 0.44ax 
 
Phos + Car (0.40) 0.51 ± 0.89cx 0.00 ± 0.00bx 0.00 ± 0.00ax 0.00 ± 0.00ax 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Meabs with a  different letter witin a row differ significantly (P<0.05) 
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TABLE 3.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Listeria monocytogenes in onion mushroom soup held at 12 ºC for 8 
days. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
2d 4d 6d 8d 
 
Control 4.62  ± 1.14az 5.86 ± 1.12ayz 7.22 ± 0.07axy 8.72 ± 0.69ax 
 
Phosvitin (60) 3.95 ± 0.69ax 4.02 ± 0.63ax 4.80 ± 0.46bcx 5.37 ± 1.33abx 
 
Carvacrol (0.20) 3.90 ± 0.08az 5.60 ± 2.13ayz 7.16 ± 0.75abxy 8.81 ± 0.18ax 
 
Carvacrol (0.40) 4.13 ± 0.40ax 4.31 ± 1.09ax 4.49 ± 1.57cx 4.77 ± 2.11bx 
 
Phos + Car (0.20) 3.94 ± 0.75ax 3.96 ± 0.78ax 4.25 ± 0.56cx 4.38 ± 0.47bx 
 
Phos + Car (0.40) 3.78 ± 0.70ax 4.00 ± 1.44ax 3.54 ± 0.96cx 3.17 ± 1.61bx 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Meabs with a  different letter witin a row differ significantly (P<0.05) 
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TABLE 4.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Salmonella enterica in onion mushroom soup held at 35 ºC for 24 
hours. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
4h 8h 12h 24h 
 
Control 7.63 ± 0.31ay 9.46 ± 1.29ax 10.28 ± 0.26awx 11.31 ± 0.02aw 
 
Phosvitin (60) 5.52 ± 0.95by 6.95 ± 0.51bxy 8.12 ± 0.50bx 10.99 ± 0.03aw 
 
Carvacrol (0.20) 6.39 ± 0.39abz 8.13 ± 0.01aby 8.85 ± 0.15abx 10.14 ± 0.17w 
 
Carvacrol (0.40) 2.15 ± 0.60cx 2.42 ± 1.02cx 3.54 ± 1.12cw 6.65 ± 0.96bw 
 
Phos + Car (0.20) 3.15 ± 0.56cx 3.12 ± 0.22cx 4.07 ± 1.15cx 6.46 ± 1.26bw 
 
Phos + Car (0.40) 0.33 ± 0.58dw 0.00 ± 00.0dw 0.00 ± 0.00dw 0.00 ± 0.00cw 
 
x
Each reported value for viable count represents the mean (standard deviation) of three independent 
replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
w,x,y,z
Means with a  different letter witin a row differ significantly (P<0.05) 
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TABLE 5.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Listeria monocytogenes in onion mushroom soup held at 35 ºC for 24 
hours. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
4h 8h 12h 24h 
 
Control 4.60 ± 0.03az 6.04 ± 0.74ay 6.51 ± 0.24ay 8.01 ± 0.52ax 
 
Phosvitin (60) 4.22 ± 0.25ax 4.42 ± 0.11bcx 4.68 ± 0.19bx 5.15 ± 0.85bcx 
 
Carvacrol (0.20) 4.71 ± 0.63az 5.60 ± 0.55abyz 6.40 ± 0.45axy 7.57 ± 0.06abx 
 
Carvacrol (0.40) 4.11 ± 0.71ax 4.19 ± 0.63bcx 4.27 ± 0.53bx 4.47 ± 0.18cdx 
 
Phos + Car (0.20) 3.99 ± 0.70ax 4.17 ± 0.44cx 4.33 ± 0.32bx 4.29 ± 0.62cdx 
 
Phos + Car (0.40) 3.42 ± 0.15ax 3.35 ± 0.36cx 3.23 ± 0.30cx 2.13 ± 1.84dx 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Meabs with a  different letter witin a row differ significantly (P<0.05) 
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CHAPTER 4 
 
GROWTH INHIBITION OF STAPHYLOCOCCUS AUREUS, ESCHERICHIA COLI 
O157:H7, AND BACKGROUND MICROFLORA BY PHOSVITIN AND CARVACROL 
ADDED TO ONION MUSHROOM SOUP 
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Abstract 
 
The antibacterial efficacy of phosvitin, or carvacrol alone, or combined against 
Staphylococcus aureus and Escherichia coli O157:H7 in brain heart infusion (BHI) broth and 
onion mushroom soup was investigated.  Broth with added phosvitin (10 - 100 mg/ml), 
carvacrol (0.09 - 0.75 mg/ml) or combinations was inoculated with S. aureus or E. coli 
O157:H7.  Broth or soup without antimicrobials served as control.  Growth curves and 
minimum inhibitory concentrations (MICs) for the pathogens in BHI (35 °C, 24 hours) were 
obtained by using a Bioscreen C turbidometer (OD 600nm).  Growth of the pathogens in 
soup (12 °C, 8 days) and (35 °C, 24 hours) was monitored by surface plating the samples on 
appropriate selective agar.  The MIC of phosvitin and carvacrol was greater than 100 mg/ml 
and 0.12 mg/ml, respectively, for S. aureus; and 80 mg/ml and 0.12 mg/ml, respectively, for 
E. coli.  No growth of S. aureus occurred in control or treated soup at 12 °C.  Phosvitin (60 
mg/ml) plus carvacrol (0.40 mg/ml) exhibited the greatest cidal effect against both 
pathogens, after day 2.  With this combination, pathogens were undetected (<10 CFU/ml) 
from day 4 through day 8. In soup (35 °C, 24hr), phosvitin (60 mg/ml) and carvacrol (0.40 
mg/ml) combination reduced viable cells of S. aureus and E. coli by 6.78 and 9.89 log 
CFU/ml, respectively.  Phosvitin concentration alone, carvacrol (0.40 mg/ml) alone, and in 
combination were also effective towards growth inhibition of soup background microflora. 
The combination of phosvitin (60 mg/ml) and carvacrol (0.40 mg/ml) is highly effective for 
controlling S. aureus and E. coli in temperature abused onion mushroom soup and has good 
potential for improving the microbial safety of this potentially hazardous food product during 
temperature abuse. 
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Introduction 
Control of human enteric foodborne pathogens to prevent of foodborne related 
illnesses is a goal of the government, food manufacturers, processors and retailers. The 
continued use of synthetic chemical preservatives to enhance microbial safety of control food 
has increased consumer health concerns, even though the use of these preservatives may be 
regarded as safe by regulatory authorities (Beuchat 2008).  In this regard, food manufacturers 
are searching for new naturally derived alternatives to address the concern of consumers.  To 
reduce chemical preservatives that are currently used in foods the following must be 
addressed when considering substitution with natural antimicrobials: assurance of 
microbiological food safety, efficacy and functionality in foods; toxicology and safety in 
food formulations; interactions with food components and other preservatives.  Other 
important considerations include: mechanism of action against microorganisms; influence on 
food quality and sensory; extraction and isolation methods, and economical production on an 
adequate scale (Sofos and others 1998; Beuchat 2008).  Naturally derived antimicrobials are 
obtained from either animal, plant, or microbial sources.     
Phosvitin is a naturally derived phosphoprotein from egg yolk, containing 
approximately 120 phosphoserine residues (Castellanie and others 2004).  The high 
phosphorus content allows phosvitin to bind up to 60 iron molecules, dependent on the 
isolation method (Mecham and Olcott 1949; Taborsky 1963; Webb and others 1973; Albright 
and others 1984).  The ability of phosvitin to remove essential nutrients such as iron from the 
environment is believed to inhibit growth of foodborne pathogens (Sattar Khan and others 
2000).  To date, antimicrobial efficacy of phosvitin has been reported in one published paper 
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(Sattar Khan and others 2000).  In that study Escherichia coli was inactivated when subjected 
to phosvitin (0.1 mg/ml) combined with heat (50 °C, 20 min) (Sattar Khan and others 2000). 
Carvacrol, (2-methyl-5-(1-methylethyl)-phenol), is an essential oil from the leaves 
and flowering plant of both oregano (Origanum vulgare) and thyme (Thymus vulgaris) (Burt, 
2004; Oussalah 2007).  The percent composition of carvacrol in oregano ranges from trace 
amounts to 82% and 2 to 45% in thyme (Lagouri and others 1993; Arrebola and others 1994; 
Burt 2004).  Antimicrobial activity of carvacrol has been studied extensively in broth model 
systems as well as several foods including: cheese (Smith-Palmer and others 2001), apple 
cider (Friedman and others 2004, Kisko and Roller 2005), fruit (kiwi and melon) (Roller and 
Seedhar 2002), carrot broth (Valero and Salmeron 2003), salad (Koutsoumanis and others 
1999),  lettuce and spinach leaves (Obaidat and Frank 2009), rice (Ultee and others 2000b), 
turkey (Juneja and Friedman 2007),  meat (Veldjuizen and others 2007;  Juneja and Friedman 
2008; Solomakos and others 2008; Friedman and others 2009), fish/seafood (Kim and others 
1995; Meljlholm and  Dalgaard, 2002;  Ravishankar and others 2010).  It has been shown to 
have stronger antimicrobial effect with increased temperature and storage time, and at a 
lower pH (Burt 2004; Friedman and others 2004).  This phenolic compound is thought to 
exert antibacterial action by causing structural and functional damage to cellular membranes 
(Sikkema and others 1995; Sivropoulou and others 1996; Ultee and others 1999).  While 
there is a growing body of knowledge on the antimicrobial effects of carvacrol, against 
various foodborne pathogens, such published research involving phosvitin is scarce.  To our 
knowledge there are no published research involving the combined use of phosvitin and 
carvacrol against Staphylococcus aureus and Escherichia coli O157:H7.  The objectives of 
the present study were: 1) to establish the minimum inhibitory concentration of both 
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phosvitin and carvacrol in brain heart infusion broth and 2) to evaluate the antimicrobial 
efficacy of phosvitin, low concentrations of carvacrol both individually and their 
combinations against foodborne human enteric pathogens and background microflora in soup 
held at 12 °C and 35 °C. 
Materials and Methods 
Bacterial cultures and culture conditions 
 Three strains of Staphylococcus aureus (ATCC 6538, ATCC 25923, and BAA-44) 
and five strains of Escherichia coli O157:H7 (FRIK125, ATCC 35150, ATCC 43894, ATCC 
43895, and 93-062) were used in the present study.  All cultures were obtained from the 
culture collection of the Microbial Food Safety Laboratory, Iowa State University, Ames, IA. 
Stock cultures were kept frozen (-70 ºC) in Brain Heart Infusion (BHI) broth (Difco, Becton, 
Dickinson, Sparks, MD) supplemented with 10% (vol/vol) glycerol.  Stock cultures were 
activated in BHI broth (pH 7.2) and incubated at 35 °C.  At least two consecutive 18 to 22-h 
transfers of each stock culture were carried out before using the cells as inocula in each 
experiment. 
Preparation of inoculum 
 An equal volume of each of the working cultures of S. aureus or E. coli O157:H7 
were combined in a sterile centrifuge tube.  The cells were harvested by centrifugation 
(10,000 x g, 10 min, 4 °C) using a Sorvall Super T21 (American Laboratory Trading, Inc., 
East Lyme, CT) and washed once in 0.1% (wt/vol) peptone. The pelleted cells were 
suspended in fresh 0.1% (wt/vol) peptone to obtain a final viable cell concentration of 
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approximately 10
9
 CFU ml
-1
.  Viable counts of the washed cell suspensions were evaluated 
by surface plating serially diluted (10-fold) samples on tryptic soy agar supplemented with 
0.6% yeast extract. The individual cell suspensions were used to inoculate BHI broth or 
commercial onion mushroom soup.  
Antimicrobials 
 Phosvitin was supplied by Dr. Dong Ahn from the Animal Science Department at 
Iowa State University, Ames, IA.  A commercial preparation of carvacrol was purchased 
from Sigma-Aldrich (Aldrich W224502).  
Total phenolic content of carvacrol 
The concentration of total phenolics of carvacrol was determined using the method 
described by Waterman and Mole (1994).  The assay involves reduction of ferric iron to the 
ferrous state by phenolic compounds that results in the formation of the Prussian blue 
complex Fe4[Fe(CN)6]3 with a potassium ferricyanide reagent.  The Prussian blue complex 
is determined colorimetrically (Khiyami and others 2005).  Two separate 1% (vol/vol) 
solutions of carvacrol in 10% (vol/vol) ethanol and deionized water were prepared.  The 
absorbance of three sub- samples from each solution was measured at 720 nm and the total 
phenolic content expressed as the number of catechin equivalents x 100.  
Preparation of treatment solutions for Bioscreen C assay 
BHI broth with added phosvitin (10, 20, 40, 60, 80, 100 mg/ml) or carvacrol (0.09, 
0.12, 0.14, 0.19, 0.38, or 0.75 mg/ml) were filter sterilized using 0.22 µm pore size Millipore 
filters (Fisher Scientific, Pittsburgh, PA).  Samples (2.5-ml) of the treatment solutions and 
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control (BHI with no added antimicrobial) were each inoculated with 25 µl of diluted (1:100) 
S. aureus or E. coli O157:H7 cell suspension to obtain a final concentration of approximately 
10
5
 CFU/ml of sample. 
Bioscreen C assay   
Aliquots (200 µl) of inoculated samples were added in triplicate to the wells of 
microtiter plate for the Bioscreen C Turbidometer (Growth Curves, Piscataway, NJ), an 
automated microbial growth analyzer and incubator.  Plates were incubated in the Bioscreen 
C at 35 °C for 24 h and the instrument was programmed to take optical density (OD) 
measurements at 600 nm every 30 min, with shaking of samples before each OD reading. 
Minimum inhibitory concentration (MIC) was defined as the lowest treatment concentration 
that completely inhibited microbial growth for 24 hr (< 0.05 OD unit increase).  
Preparation and inoculation of soup  
Dehydrated onion mushroom soup/dip mix was purchased from a local grocery store. 
The soup mix was hydrated with sterile distilled water and prepared according to the 
directions stated on the package.  Soup ingredients are shown in Table 1.  After boiling, the 
soup was tempered to ~ 35 °C and 10-ml portions of the soup were aseptically transferred 
into sterile 30 ml screw cap Pyrex tubes.  Phosvitin, carvacrol or combinations were added to 
each tube to give the following concentrations: phosvitin (60 mg/ml), carvacrol (0.20 mg/ml 
or 0.40 mg/ml), phosvitin (60 mg/ml) + carvacrol (0.20 mg/ml) and phosvitin (60 mg/ml) + 
carvacrol (0.40 mg/ml).  Phosvitin was added to the tubes prior to the addition of the soup to 
prevent aggregation and facilitate its dissolving in the soup.  Tubes of soup without added 
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antimicrobial served as control.  The tubes of soup were then warmed or cooled to the 
desired temperature (12 °C or 35 °C).  Tubes of soup with added antimicrobials were mixed 
by vortexing and inoculated with a suspension of washed cells of the foodborne pathogens to 
give a final cell concentration of approximately 10
5
 CFU/ml for each pathogen.  After 
inoculation, each tube of soup was gently mixed by vortexing and held at either 12 °C or 35 
°C.  
Microbiological analysis 
Inoculated tubes of soup held at 12 °C were tested for survivors of the pathogens 
every 2 days for a total of 8 days whereas, soup held at 35 °C were tested at 4, 8, 12 and 24 h.  
Ten-fold serial dilutions of the soup were prepared using 0.1% (vol/vol) peptone with added 
Tween 80 (0.5% v/v).  Aliquots (1.0 ml or 0.1ml) of the soup or diluted samples of soup were 
surface plated (in duplicate) on mannitol salt agar (for S. aureus) and sorbitol MacConkey 
agar (for E.coli).  All inoculated plates were incubated at 35 °C for 48h before counting 
bacterial colonies.  
Measurement of pH and water activity 
 The initial pH and water activity of each sample of soup including controls were 
measured at day 0 (prior to inoculation).  Measurements of pH were also taken periodically 
during storage of the soup at 12 °C or 35 °C.  Measurements of pH were taken using an 
Orion Model 525 pH meter (Orion Research, Inc., Boston, Massachusetts) fitted with a glass 
electrode.  Water activity measurements were taken using the Aqualab CX2 water activity 
meter (Decagon Services, Pullman, Washington). 
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Statistical analysis 
Three independent replications of each experiment were performed. Mean numbers of 
survivors S. aureus or E.coli O157:H7 were statistically analyzed using SAS statistical 
software version 8.1 (SAS Institute Inc., Cary, N.C.).  Treatment means were evaluated for 
statistically significant differences using Tukey’s test.  Significant differences were defined 
at P < 0.05 for all the experimental data. 
Results 
Growth inhibition by phosvitin in BHI broth 
The effect of phosvitin on the growth of Staphylococcus aureus and Escherichia coli 
O157:H7 in Brain Heart Infusion (BHI) broth is shown in Figures 1 and 2.  For S. aureus, the 
optical density (OD) of control and broth containing 10 and 20 mg/ml phosvitin increased 
rapidly and slightly exceeded an OD of 0.8 after 17 hours.  Growth inhibition and extension 
of the lag phase of S. aureus increased with higher phosvitin concentrations.  The MIC of 
phosvitin for S. aureus was greater than 100 mg/ml.  For E. coli O157:H7, the OD of the 
culture increased from 0.1 (at 3h) to greater than 1.2 (at 17h).  All phosvitin concentrations, 
except 10 mg/ml, inhibited growth of E. coli O157:H7 with higher concentrations causing 
more pronounced growth inhibition.  Phosvitin at 80 and 100 mg/ml were bacteriostatic. 
Greater extensions of the lag phase and lower maximum OD values were observed with 
increased phosvitin concentrations.  The MIC of phosvitin for E. coli O157:H7 was 80 
mg/ml. 
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Growth inhibition by carvacrol in BHI broth 
Growth of S. aureus and E. coli O157:H7 in BHI supplemented with various 
concentrations of carvacrol is shown in Figures 3 and 4.  The OD of control increased from 
0.1 to greater than 0.6 within 18 hours.  Increase in OD occurred only in BHI containing 0.09 
mg/ml carvacrol.  At 24 hours the control and carvacrol (0.09 mg/ml)-containing cultures 
achieved an OD > 0.7 and 0.45, respectively.  All other concentrations of carvacrol (0.12 - 
0.75 mg/ml) completely inhibited growth of the organism.  The MIC of carvacrol for S. 
aureus was 0.12 mg/ml.  Except for 0.09 mg/ml, all other carvacrol concentrations tested 
against E. coli O157:H7 completely inhibited growth of the pathogen. Brain heart infusion 
broth with 0.09 mg/ml decreased the growth of the pathogen compared to control.  At 18 
hours the OD of control and carvacrol (0.09 mg/ml) was ~ 1.0 and 0.65, respectively.  The 
MIC of carvacrol for E. coli O157:H7 was 0.12 mg/ml. 
Growth inhibition by phosvitin and carvacrol in onion mushroom soup at 12 ºC 
The total phenolic content of the 1% solution of carvacrol was 0.98 catechin 
equivalents.  This result coincides with the manufacturer’s claim of “up to 98% total 
polyphenols”.  The initial pH and water zctivity of the soup was 6.1 and 0.994, respectively.  
The initial viable count of S. aureus or E. coli O157:H7 in onion mushroom soup was Log 
5.0 CFU/ml.  Viable counts of S. aureus or E. coli O157:H7 in soup (12 °C) with phosvitin 
alone or combined with carvacrol are shown in Tables 2 and 3.  No growth of S. aureus 
occurred in control or treated soup at 12 °C.  In control soup viable numbers of S. aureus 
decreased by 0.86 Log CFU/ml at 4 days and numbers of surviving bacteria remained 
constant throughout the storage period.  Numbers of survivors in soup with phosvitin (60 
 112 
 
mg/ml) or carvacrol (0.20 mg/ml) alone were not significantly (P>0.05) different from those 
in control soup.  Carvacrol (0.40 mg/ml) and phosvitin (60 mg/ml) plus carvacrol (0.20 or 
0.40mg/ml) decreased cell survival during the storage period..  The combination of phosvitin 
and carvacrol (0.40 mg/ml) was cidal to S. aureus; initial counts decreased by 4.32 log 
CFU/ml at 2 days of storage. Viable counts of the pathogen decreased further and were 
undetectable (<10 CFU/ml) from day 4 to day 8. 
In control soup at 12 °C viable numbers of E. coli O157:H7 increased to 6.90 log 
CFU/ml at day 8.  Phosvitin (60mg/ml) exerted a bacteriostatic action on the pathogen; no 
growth occurred throughout the duration of the study.  At day 2, carvacrol (0.20 mg/ml) 
caused about a 1 log reduction in viable counts compared to the control, and number of 
survivors remained constant up to 8 days.  By day 2, carvacrol (0.40 mg/ml) alone and the 
combination of phosvitin and carvacrol (0.40mg/ml) caused a log reduction of 2.39 and 4.05, 
respectively.  After day 2 viable cells were undetected (<10 CFU/ml) in soup that contained 
either of the two treatments. 
Growth inhibition by phosvitin and carvacrol in onion mushroom soup at 35 ºC 
 Tables 4 and 5 show the effect of phosvitin, carvacrol and combinations against S. 
aureus and E. coli O157:H7 in onion mushroom soup (35 °C).  In control soup viable 
numbers of S. aureus increased from 5.60 log at 4 hours to 8.83 log CFU/ml at 24 hours of 
incubation (Table 4).  Compared to control, phosvitin alone strongly inhibited growth of the 
pathogen for 12 hours (P<0.05).  Carvacrol (0.20 mg/ml) alone failed to suppress the growth 
of the pathogen; however, when it was combined with phosvitin the growth inhibitory effect 
of that combination was significantl (P<0.05).  Viable counts in soup that contained carvacrol 
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(0.4 mg/ml) alone and the combination of phosvitin and carvacrol (0.40 mg/ml) were 
significantly (P< 0.05) lower than from the control after 4 hours; however, there was no 
significant difference between these two treatments (P >0.05).  At 24 hours carvacrol (0.40 
mg/ml) and phosvitin plus carvacrol (0.40 mg/ml) reduced cell survival by 6.33 and 6.78 log 
CFU/ml, respectively. 
Viable numbers of E. coli O157:H7 in control soup increased from 7.59 log at 4 hours 
to 10.69 log CFU/ml at 24 hours of incubation (Table 5).  Viable counts of the pathogen in 
soup with added phosvitin (60 mg/ml), carvacrol (0.2 or 0.4 mg/ml) and their combinations 
were significantly (P<0.05) lower than those of the control for the first four hours of 
incubation at 35°C.  Phosvitin strongly inhibited the growth of the microorganisms for the 
first 8 hours.  Carvacrol (0.20 mg/ml) lost effectiveness to suppress the growth of E. coli 
O157:H7 at 8 hours whereas, carvacrol (0.40mg/ml) alone or phosvitin combined with 
carvacrol (0.20 mg/ml) was effective in suppressing growth of the pathogen within that 8-
hour period.  Viable counts of soup with the combination of phosvitin and 0.4mg/ml of 
carvacrol were significantly (P< 0.05) lower than those of control throughout the entire 
storage period.  Phosvitin combined with the highest level of carvacrol (0.40 mg/ml) 
produced a 9.89 log reduction in viable counts at 24 hours, compared to the control.  
In addition to the antimicrobial activity of phosvitin and carvacrol against S. aureus 
and E. coli, growth inhibition of background microflora present in soup at 35° C for 12 hours 
(Figure 5) was evaluated.  Background microflora in control soup increased from 1.4 log 
CFU/ml at time 0 to 4.28 log at 12 hours.  At 12 hour, phosvitin (60 mg/ml), carvacrol (0.40 
mg/ml), and their combination were significantly (P<0.05) different from the control.  
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Phosvitin alone, carvacrol alone, and the phosvitin carvacrol combination reduced microflora 
by 1.39, 2.78, and 3.19 log CFU/ml, respectively. 
Discussion 
In recent years consumer awareness of food safety has increased substantially.  Also 
consumers are demanding more natural food preservatives instead of synthetic ones.  Such 
changes in consumer attitude are rapidly affecting the actions of the food industry.  Food 
processors are now seeking naturally derived antimicrobials to substitute for currently used 
synthetic additives.  Some naturally-derived antimicrobials include plant essential oils (EO) 
and their components (Burt, 2004).  One component of EO that has very good antimicrobial 
activity is carvacrol.  In the present study we used carvacrol and phosvitin (an antimicrobial 
protein from egg yolk) to control S. aureus and E. coli O157:H7 in an onion mushroom soup 
held at abusive temperatures.  While several studies have been published to demonstrate the 
antibacterial efficacy of carvacrol, to date there is only one published report on the 
antibacterial effect of phosvitin (Sattar Khan and others 2000).  In the present study phosvitin 
inhibited the growth of S. aureus and E. coli O157:H7 in BHI broth in a dose dependent 
manner (Figures 1 and 2). E. coli O157:H7 seemed to be more sensitive to phosvitin 
compared to S. aureus.  This observed sensitivity might be due to the relatively strong 
chelation ability of phosvitin (Sattar Khan and others 2000).  Carvacrol proved to be a more 
potent antimicrobial compared to phosvitin due to the very low concentrations required to 
inhibit the pathogens tested in BHI broth the present study.  
It is generally well recognized that concentrations of antimicrobials that are effective 
in laboratory media require higher concentrations to be effective in actual food products.  
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Certain antimicrobials, such as essential oils, or their components, may effectively control 
microorganisms at concentrations that alter sensory quality.  To circumvent this issue of high 
concentration, it might be best to use essential oils in system of antimicrobials consistent 
with hurdle technology concept (Adams and others 2003; Nychas and Skandamis 2003; 
Roller and Board 2003).  In the present study we were able to use relatively low 
concentrations (0.20 and 0.40 mg/ml) of carvacrol were combined with phosvitin to control 
pathogens in onion mushroom soup held at abusive temperatures.  Veldhuizen et al. (2007) 
reported reduced antimicrobial activity of similar concentrations of carvacrol when combined 
with egg yolk.  Our data show that phosvitin alone extracted from the egg yolk actually 
increased the efficacy of carvacrol. In all instances the combination proved to strongly 
inhibitory and at times cidal to the pathogens (Tables 2 and 3).  We intentionally held the 
soup at 12 °C and 35 °C to simulate temperature abuse situations.  Both of these temperatures 
fall within the temperatue danger zone in which pathogenic bacteria can grow rapidly and 
reach high populations within 4 hours.  At both temperatures the combination of carvacrol 
and phosvitin was very effective in controlling S. aureus and E. coli O157:H7 in the soup.  
That combination also inhibited growth of background microflora in onion mushroom soup. 
Based on these findings the combination of phosvitin and carvacrol has good potential for 
enhancing the microbial safety of onion mushroom soup and preventing microbial spoilage 
of this product.  Further research is needed to determine the influence of combined 
antimicrobials on the sensory charachteristics and quality of food. 
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TABLE 1. 
a
Ingredients in dehydrated onion and mushroom soup/dip mix. 
Cornstarch  
Dehydrated onions  
Salt  
Monosodium glutamate  
Maltodextrin  
Wheat flour  
Dehydrated mushrooms  
Partially hydrogenated soybean oil  
Hydrolyzed protein (corn, soy, wheat)  
Autolyzed yeast extract  
Caramel color  
Onion powder  
Guar gum  
Garlic powder  
Natural flavors  
Disodium guanylate  
Disodium inosinate  
*Sodium 700 mg- 29% 
a
 Ingredients are listed in the same order as they appear on the label of the package 
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Figure 1. Growth of Staphylococcus aureus in BHI broth (35 °C) supplemented with 
various concentrations of phosvitin. 
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Figure 2. Growth of Escherichia coli O157:H7 in BHI broth (35 °C) supplemented with 
various concentrations of phosvitin. 
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Figure 3. Growth of Staphylococcus aureus in BHI broth (35 °C) supplemented with 
various concentrations of carvacrol. 
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FIGURE 4. Growth of Escherichia coli O157:H7 in BHI broth (35 °C) supplemented 
with various concentrations of carvacrol. 
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FIGURE 5. The effect of phosvitin (60 mg/ml), carvacrol (0.40 mg/ml) and their 
combinations against background microflora in soup at 35 °C. 
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TABLE 2.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Staphylococcus aureus in onion mushroom soup held at 12 ºC for 8 
days. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
2d 4d 6d 8d 
 
Control 5.02 ± 0.54ax 4.16 ± 0.20aby 4.29 ± 0.05axy 4.32 ± 0.25axy 
 
Phosvitin (60) 3.76 ± 0.67abx 3.79 ± 0.44abx 3.60 ± 0.48ax 3.40 ± 0.32abx 
 
Carvacrol (0.20) 4.55 ± 0.05ax 4.36 ± 0.92ax 3.97 ± 0.51ax 3.88 ± 0.71abx 
 
Carvacrol (0.40) 2.70 ± 0.49bx 2.59 ± 1.03bx 2.05 ± 0.63bx 0.80 ± 0.72cx 
 
Phos + Car (0.20) 3.81 ± 0.60abx 3.47 ± 0.49abx 3.19 ± 0.63abx 2.68 ± 0.77bx 
 
Phos + Car (0.40) 0.68 ± 1.18cx 0.00 ± 0.00cx 0.00 ± 0.00cx 0.00 ± 0.00cx 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Meabs with a  different letter witin a row differ significantly (P<0.05) 
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TABLE 3.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Escherichia coli O157:H7 in onion mushroom soup held at 12 ºC for 8 
days. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
2d 4d 6d 8d 
 
Control 4.80 ± 0.20ax 5.66 ± 1.18ax 6.74 ± 3.37ax 6.90 ± 3.47ax 
 
Phosvitin (60) 4.45 ± 0.74ax 4.54 ± 0.38abx 4.50 ± 0.32abx 4.62 ± 0.84ax 
 
Carvacrol (0.20) 3.82 ± 0.36abx 3.67 ± 1.53abx 3.63 ± 3.71abx 3.09 ± 5.35ax 
 
Carvacrol (0.40) 2.41 ± 0.74bx 0.00 ± 0.00cy 0.00 ± 0.00by 0.00 ± 0.00ay 
 
Phos + Car (0.20) 3.79 ± 0.52abx 2.99 ± 0.36bx 1.70 ± 1.87abx 1.20 ± 2.08ax 
 
Phos + Car (0.40) 0.75 ± 0.77cx 0.00 ± 0.00cx 0.00 ± 0.00bx 0.00 ± 0.00ax 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Meabs with a  different letter witin a row differ significantly (P<0.05) 
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TABLE 4.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Staphylococcus aureus in onion mushroom soup held at 35 ºC for 24 
hours. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
4h 8h 12h 24h 
 
Control 5.60 ± 0.58az 7.2 ± 0.58ay 8.28 ± 0.74axy 8.83 ± 0.25ax 
 
Phosvitin (60) 4.38 ± 0.88ax 4.78 ± 1.22bx 5.07 ± 1.54bcx 6.06 ± 1.44abx 
 
Carvacrol (0.20) 4.96 ± 0.69ay 6.08 ± 0.62abx 6.77 ± 0.57abx 7.48 ± 0.24abx 
 
Carvacrol (0.40) 4.15 ± 0.86ax 4.05 ± 0.80bx 3.85 ± 0.94cx 2.50 ± 0.35cdx 
 
Phos + Car (0.20) 4.11 ± 0.88ax 4.43 ± 0.96bxy 4.03 ± 1.09bcx 5.00 ± 1.94bcx 
 
Phos + Car (0.40) 3.69 ± 1.03ax 3.72 ± 0.85bx 3.51 ± 1.07cx 2.05 ± 0.56dx 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Meabs with a  different letter witin a row differ significantly (P<0.05) 
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TABLE 5.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
carvacrol against Escherichia coli O157:H7 in onion mushroom soup held at 35 ºC for 24 
hours. 
 
Viable count (Log10 CFU/ml)
x 
Treatment (mg/ml) 
 
4h 8h 12h 24h 
 
Control 7.59 ± 0.07az 9.62 ± 0.30ay 9.99 ± 0.12ay 10.69 ± 0.27ax 
 
Phosvitin (60) 4.54 ± 0.95bcy 5.29 ± 1.51bcy 6.12 ± 0.05aby 9.23 ± 0.17ax 
 
Carvacrol (0.20) 4.98 ± 0.36z 8.32 ± 0.05aby 9.23 ± 0.11ax 8.89 ± 0.08ax 
 
Carvacrol (0.40) 2.35 ± 0.82cdx 3.89 ± 2.16cdx 4.37 ± 3.79bcx 5.43 ± 4.71abx 
 
Phos + Car (0.20) 4.52 ± 0.81bcx 4.63 ± 0.84cdx 5.44 ± 1.43abcx 5.11 ± 4.43abx 
 
Phos + Car (0.40) 1.58 ± 1.37dx 1.32 ± 1.22dx 1.26 ± 1.20cx 0.80 ± 0.72bx 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Meabs with a  different letter witin a row differ significantly (P<0.05) 
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Abstract 
 
The objective of this research was to identify antimicrobial activities of phosvitin, or nisin 
alone, or in combination against Salmonella enterica, Escherichia coli O157:H7 and 
Staphylococcus aureus in brain heart infusion (BHI) broth and abused soup held at unsafe 
temperatures.  Broth supplemented with phosvitin (10 - 100 mg/ml), nisin (500 or 1000 IU) 
or combinations was inoculated (10
5
 CFU/ml) with S. enterica, E. coli O157:H7 or S. aureus.  
Broth or soup without antimicrobials served as control.  Growth of S. enterica, E. coli, and S. 
aureus in BHI (35 °C, 24 hours) was monitored using a Bioscreen C turbidometer (OD 
600nm).  Growth of the pathogens in soup (12 °C, 8 days and 35 °C, 24 hours) were 
monitored by surface plating.  In BHI broth minimum inhibitory concentration (MIC) of 
phosvitin was 80 mg/ml for both S. enterica and E. coli O157:H7 and greater than 100 mg/ml 
for S. aureus.  Phosvitin at the concentration range of 20-100 mg/ml inhibited growth of S. 
enterica and E. coli O157:H7; 80 mg/ml was bacteriostatic for both organisms. S. aureus was 
less sensitive to phosvitin compared to the two Gram-negative pathogens.  For S. enterica 
and E. coli O157:H7 control cultures grew rapidly in soup and reached about 6.90 log 
CFU/ml in 8 days.   
Phosvitin inhibited growth of S. enterica and E. coli O157:H7 for 6 and 8 days, respectively 
whereas, nisin (1000 IU) was ineffective in preventing growth of those pathogens.  No 
growth of S. aureus occurred in control or treated soup at 12 °C.  Irrespective of storage 
temperature (12 °C or 35 °C), phosvitin combined with either concentration of nisin did not 
offer enhanced antibacterial effect above that provided by phosvitin used alone.   
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Introduction 
Foodborne illnesses caused by human enteric pathogens such as Salmonella enterica, 
Escherichia coli O157:H7 and Staphylococcus aureus are a significant problem and cause 
major health concerns annually (Mead et al., 1999).  For several decades synthetic food 
preservatives such as nitrites, sulfites, and parabens have been used to control foodborne 
pathogens and spoilage microorganisms (Jay, 2005).  The extensive use of synthetic 
chemicals for antimicrobial or other functions has resulted in the widespread movement 
towards use of natural antimicrobials as consumers become more health conscious.  The food 
industry is looking to use “natural”, cost efficient antimicrobials from plant, microbial and/or 
animal sources, as replacements.  The use of hurdle technology will allow natural 
antimicrobials to be combined, increasing microbial safety, decreasing high individual 
concentrations and widening the spectrum of antimicrobial activity (Leistner, 2000). 
Phosvitin is a metal chelating protein found in egg yolk.  Egg yolk participates in 
embryonic development by providing essential nutrients for the developing embryo. 
Phosvitin, a 35 kDa phosphoglycoprotein, is the major egg yolk protein.  It is currently 
recognized as the most phosphorylated protein in nature.  Over half of the amino acids 
present in phosvitin are serine, of which 90% are phosphorylated (Taborsky, 1983; Byrne et 
al., 1984; Clark, 1985).  The numerous phosphorylated serine residues have a strong affinity 
for divalent metals and contribute to the chelating ability of phosvitin (Osaki et al., 1975; 
Grogan and Taborsky, 1987).  This property allows binding to nutrients in the environment 
and binding to membranes of bacteria.  To date there is only one published paper addressing 
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the antimicrobial properties of phosvitin (Sattar Khan et al., 2000).  These authors found that 
the combination of phosvitin and heat (50 °C) inactivated Escherichia coli O157:H7. 
Nisin, is produced as a defense response to some lactic acid bacteria (LAB), 
specifically Lactococcus lactis subspecies lactis.  To date, nisin is the only Generally 
Recognized As Safe (GRAS) commercially available bacteriocin approved for use as a 
preservative additive in over fifty countries (FAO/WHO, 1969; FDA, 1988; Jay, 2000).  
Nisin has been used as a natural antimicrobial peptide and is bactericidal against some strains 
of following Gram-positive bacteria: Alicyclobaccillus (Komitopoulou et al., 1999), Bacillus 
(Jaquette and Beuchat, 1998), Brochothrix (Cutter and Siragusa, 1996), Clostridium 
(Okereke and Montville, 1992), Enterococcus (Laukova, 1995), Lactobacillus (Chun and 
Hancock, 2000) Listeria (Knight et al., 1999), Micrococcus (Dutreux et al., 2000), and 
Staphylococcus (Thomas and Wimpenny, 1996).  Nisin is unable to penetrate the cell wall of 
yeast and Gram-negative bacteria (Kordel et al., 1989; Boziaris and Adams, 1999).  In 
susceptible vegetative cells the primary site of action by nisin is the cytoplasmic membrane 
(Abee et al., 1995; Kuwano et al., 2005).  This bacteriocin has the ability to bind to the 
membrane and form pores that destroy the membrane integrity.  Pore formation leads to 
leakage of K+ ions and ATP, depletion of the proton motive force, and depolarization of 
transmembrane potential, resulting in cell death (Sahl, 1991; Bruno and Montville, 1993; 
Millette et al., 2004). 
While there is an extensive knowledge base on the antimicrobial effects of nisin 
against various foodborne pathogens, such published research involving phosvitin is scarce.  
In fact there is only one published paper on the effects of phosvitin on E. coli O157:H7 
(Sattar Khan, 2000).  Also, to our knowledge there is no published research involving the 
 135 
 
combined use of phosvitin and nisin against Salmonella enterica, Escherichia coli O157:H7, 
or Staphylococcus aureus.  The first objective of the present study was to establish the 
minimum inhibitory concentration of phosvitin and nisin for S. enterica, E. coli O157:H7 and 
S. aureus in laboratory broth medium.  The second objective was to evaluate the 
antimicrobial effectiveness of phosvitin, nisin, and their combination against those same 
foodborne pathogens in a commercial-type onion mushroom soup. 
Materials and Methods 
Bacterial cultures and culture conditions. Five serotypes of Salmonella enterica 
(Enteritidis-ATCC13076, Heidelberg, Typhimurium-ATCC 14802, Gaminara-8324, 
Oranienburg-9329), five strains of Escherichia coli O157:H7 (FRIK125, ATCC 35150, 
ATCC 43894, ATCC 43895, and 93-062) and three strains of Staphylococcus aureus (ATCC 
6538, ATCC 25923, and BAA-44) were used in the present study.  All cultures were 
obtained from the culture collection of the Microbial Food Safety Laboratory, Iowa State 
University, Ames, IA.  Stock cultures were kept frozen (-70 ºC) in Brain Heart Infusion 
(BHI) broth (Difco, Becton, Dickinson, Sparks, MD) supplemented with 10% (vol/vol) 
glycerol.  Stock cultures were activated in BHI broth (pH 7.2) and incubated at 35 °C. At 
least two consecutive 18 to 22-h transfers of each stock culture were carried out before using 
the cells as inocula in each experiment. 
 Preparation of inoculum.  An equal volume of the individual working cultures of L. 
monocytogenes or S. enterica were combined in a sterile centrifuge tube.  The cells were 
harvested by centrifugation (10,000 x g, 10 min, 4°C) using a Sorvall Super T21 (American 
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Laboratory Trading, Inc., East Lyme, CT) and washed once in 0.1% (wt/vol) peptone.  The 
pelleted cells were suspended in fresh 0.1% (wt/vol) peptone to obtain a final viable cell 
concentration of approximately 10
9
 CFU ml
-1
.  Viable counts of the washed cell suspensions 
were evaluated by surface plating serially diluted (10-fold) samples on tryptic soy agar 
supplemented with 0.6% yeast extract.  The individual cell suspensions were used to 
inoculate BHI broth or commercial onion mushroom soup.  
Antimicrobials.  Phosvitin was supplied by Dr. Dong Ahn from the Animal Science 
Department at Iowa State University, Ames, IA.  Nisin was purchased from Danisco 
(Nisaplin, Danisco Cultor USA) and was reported to be 2.5% pure (1000 IU/mg). 
Total phenolic content of carvacrol.  The concentration of total phenolics of 
carvacrol was determined using the method described by Waterman and Mole (1994).  The 
assay involves reduction of ferric iron to the ferrous state by phenolic compounds that results 
in the formation of the Prussian blue complex Fe4[Fe(CN)6]3 with a potassium ferricyanide 
reagent.  The Prussian blue complex is determined colorimetrically (Khiyami et al., 2005).  
Two separate 1% (vol/vol) solutions of carvacrol in 10% (vol/vol) ethanol and deionized 
water were prepared. The absorbance of three sub- samples from each solution was measured 
at 720 nm and the total phenolic content expressed as the number of catechin equivalents x 
100.  
Preparation of treatment solutions for Bioscreen C assay.  BHI broth with added 
phosvitin (10, 20, 40, 60, 80, 100 mg/ml) or nisin (500 or 1000 IU) were filter sterilized 
using 0.22 µm pore size Millipore filters (Fisher Scientific, Pittsburgh, PA).  Samples (2.5-
ml) of the treatment solutions and control (BHI with no added antimicrobial) were each 
inoculated with 25 µl of diluted (1:100) S. enterica, E. coli O157:H7 or S. aureus cell 
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suspension to obtain a final concentration of approximately 10
5
 CFU/ml of sample. 
Bioscreen C assay.  Aliquots (200-µl) of inoculated samples were added in triplicate 
to the wells of microtiter plate for the Bioscreen C Turbidometer (Growth Curves, 
Piscataway, NJ), an automated microbial growth analyzer and incubator.  Plates were 
incubated in the Bioscreen C at 35 °C for 24 h and the instrument was programmed to take 
optical density (OD) measurements at 600 nm every 30 min, with shaking of samples before 
each OD reading.  Minimum inhibitory concentration (MIC) was defined as the lowest 
treatment concentration that completely inhibited microbial growth for 24 hr (< 0.05 OD unit 
increase).  
Preparation and inoculation of soup.  Dehydrated onion mushroom soup/dip mix 
was purchased from a local grocery store.  The soup mix was hydrated with sterile distilled 
water and prepared according to the directions stated on the package. Soup ingredients are 
shown in Table 1.  After boiling, the soup was tempered to ~ 35 °C and 10-ml portions of the 
soup were aseptically transferred into sterile 30 ml screw cap pyrex tubes. Phosvitin, nisin or 
combinations were added to each tube to give the following concentrations: phosvitin (60 
mg/ml), nisin (500 IU or 1000IU), phosvitin (60 mg/ml) + nisin (500 IU) (S. aureus only) 
and phosvitin (60 mg/ml) + nisin (1000 IU).  Phosvitin was added to the tube prior to the 
addition of the soup to prevent aggregation and facilitate its dissolving in the soup.  Tubes of 
soup without added antimicrobial served as control.  The treatments were then warmed or 
cooled to the target temperature.  Tubes of soup with added antimicrobials were mixed by 
vortexing and inoculated with a suspension of washed cells of the foodborne pathogens to 
give a final cell concentration of approximately 10
5
 CFU/ml for each pathogen.  After 
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inoculation, each tube of soup was gently mixed by vortexing and held at either 12 °C or 35 
°C.  
Microbiological analysis.  Inoculated tubes of soup held at 12 °C were tested for 
survivors of the pathogens every 2 days for a total of 8 days whereas, soup held at 35 °C 
were tested at 4, 8, 12 and 24 h.  Ten-fold serial dilutions of the soup were prepared using 
0.1% (vol/vol) peptone with added Tween 80.  Aliquots (1.0 ml or 0.1ml) of the soup or 
diluted samples of soup were surface plated (in duplicate) on xylose lysine desoxycolate 
(XLD) agar (for S. enterica), sorbitol MacConkey agar (for E.coli) and mannitol salt agar 
(for S. aureus).  All inoculated plates were incubated at 35 °C for 48h before counting 
bacterial colonies.  
Measurement of pH and water activity. The initial pH and water activity of each 
sample of soup including controls was measured at day 0 (prior to inoculation).  
Measurements of pH were also taken periodically during storage of the soup at 12 °C or 35 
°C.  Measurements of pH were taken using an Orion Model 525 pH meter (Orion Research, 
Inc., Boston, Massachusetts) fitted with a glass electrode.  Water activity measurements were 
taken using the Aqualab CX2 water activity meter (Decagon Services, Pullman, 
Washington). 
Statistical analysis.  Three independent replications of each experiment were 
performed. Mean numbers of survivors S. enterica, E. coli O157:H7, or S. aureus were 
statistically analyzed using SAS statistical software version 8.1 (SAS Institute Inc., Cary, 
N.C.).  Treatment means were evaluated for statistically significant differences using Tukey’s 
test. Significant differences were defined at P < 0.05 for all the experimental data. 
 139 
 
Results 
Inhibitory effect of phosvitin in BHI broth. Figures 1, 2 and 3 show the effect of 
various concentrations of phosvitin on the growth of S. enterica, E. coli O157:H7 and S. 
aureus, respectively, in Brain Heart Infusion (BHI) broth at 35 °C.  The initial OD for all the 
cultures at time 0 was approximately 0.1.  Phosvitin at the concentration range of 20 -100 
mg/ml inhibited growth of S. enterica and E. coli O157:H7; 80 mg/ml was bacteriostatic for 
both organisms (Figures 1 and 2).  Also increased lag phase and lower maximum OD values 
were observed with increased phosvitin concentrations.  Compared to the two Gram-negative 
pathogens, S. aureus was less sensitive to phosvitin.  Absolutely no growth inhibition of this 
pathogen occurred at phosvitin concentrations of 10 and 20 mg/ml.  Also, growth of the 
pathogen occurred at 80 and 100 mg/ml which were bacteriostatic for S. enterica and E. coli 
O157:H7. 
Inhibitory effect of phosvitin/nisin combinations in BHI broth.  Figures 4, 5, and 
6 show the effect of phosvitin and phosvitin/nisin conbinations on growth of S. enterica, E. 
coli O157:H7, and S. aureus in BHI.  Nisin (500 or 1000 IU) was ineffective against S. 
enterica and E. coli O157:H7; both pathogens grew equally well in control and in BHI with 
added nisin.  All combinations of phosvitin and nisin were more inhibitory than nisin but 
similar in inhibitory action to phosvitin alone at the concentration corresponding to the 
phosvitin in the combination (Figures 4 and 5).  For S. aureus, nisin (500 and 1000 IU) 
completely inhibited growth of the organism.  Except for 20 mg/ml phosvitin, all other 
phosvitin concentrations (40 and 60 mg/ml) were growth inhibitory.  Combinations of 
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phosvitin and nisin were less effective than nisin alone but similar in inhibitory action to 
phosvitin alone at the concentration corresponding to the phosvitin in the combination. 
Antibacterial effect of phosvitin and nisin in soup at 12 °C.  The total phenolic 
content of the 1% solution of carvacrol was 0.98 catechin equivalents.  This result coincides 
with the manufacturer’s claim of “up to 98% total polyphenols”.  The initial pH of the soup 
was 6.1 and water activity 0.994.  Tables 2, 3, and 4 show viable counts of S. enterica, E. coli 
O157:H7 and S. aureus, respectively, in onion mushroom soup (12 °C) with phosvitin, nisin, 
or combinations of those antimicrobials.  The initial viable count for S. enterica, E. coli 
O157:H7, or S. aureus, in soup was ~ 10
5
 CFU/ml.  For S. enterica and E. coli O157:H7 
control cultures grew rapidly and reached about 6.90 log CFU/ml in 8 days.  Phosvitin 
inhibited growth of S. enterica and E. coli O157:H7 for 6 and 8 days, respectively whereas, 
nisin (1000 IU) was ineffective in preventing growth of those pathogens.  Viable counts of 
the pathogens in soup with the combination of phosvitin and nisin were not significantly 
different from those of control or other treatments (Figures 2 and 3). 
No growth of S. aureus occurred in control or treated soup at 12 °C.  In control soup 
viable numbers of S. aureus decreased and survivors remained constant throughout the 
storage period.  Viable counts of the pathogen in soup with phosvitin (60 mg/ml) were not 
significantly (P>0.05) different from the control after 2 days.  Both nisin (500 and 1000 IU) 
concentrations alone were significantly different from the control.  At day 2 a log reduction 
of 2.75 and 3.19 was seen for 500 IU and 1000 IU, viable cells continued to decrease a 
through 8 days.  Phosvitin combined with either concentration of nisin similarly increased the 
effectiveness of phosvitin alone.   
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Antibacterial effect of phosvitin and nisin in soup at 35 °C. Tables 5, 6, and 7 
show the effect of phosvitin, nisin, and combinations against S. enterica, E. coli O157:H7 
and S. aureus in onion mushroom soup (35 °C).  In control soup viable numbers of S. 
enterica increased from 7.63 log at 4 hours to 11.31 log CFU/ml at 24 hours of incubation.  
Viable counts of the pathogen in soup with phosvitin alone were significantly (P<0.05) 
different from those of control for the first 12 hours of the study.  Viable counts in soup with 
nisin (1000 IU) alone were not significantly (P>0.05) different from those of the control.  
Phosvitin plus nisin (1000 IU) also extended the lag phase of growth and was significantly 
different from other treatments and control at 24 hours of incubation (Table 5).  At 24 hours 
the viable count of S. enterica was 2.16 log CFU/ml less than that of the control. 
In control soup viable numbers of E. coli O157:H7 increased from 7.59 log at 4 hours 
to 10.69 log CFU/ml at 24 hours of incubation.  Phosvitin (60 mg/ml) was bacteriostatic, 
limiting the growth of the microorganisms for the first 8 hours.  Phosvitin was significantly 
(P<0.05) different from the control the entire duration of the study.  Nisin (1000 IU) alone 
was similar to the control and was ineffective in growth suppression of E. coli O157:H7.  The 
combination of phosvitin and nisin was similar to phosvitin alone for the first 12 hours.  At 
24 hours, this combination was the most effective reducing cell viability by 2.59 log CFU/ml. 
In control soup viable numbers of S. aureus increased from 5.60 log at 4 hours to 8.83 
log CFU/ml at 24 hours of incubation.  Phosvitin alone was bacteriostatic for the first 12 
hours, and was significantly (P<0.05) different from the control at 8 and 12 hours of the 
study.  Both nisin (500 and 1000 IU) concentrations and combinations were significantly (P 
< 0.05) different from the control for up to 12 hours. Nisin (500 and 1000) initially reduced 
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viable cells by 4 hours, and gradually increased as time progressed over the remaining 18 
hours.  After 12 hours both nisin concentrations were no longer different from the control, 
however the two combinations were significantly (P< 0.05) different from the control at 24 
hours.  Phosvitin combined with nisin 500 IU and nisin 1000 IU reduced survivors by 3.15 
and 4.31, respectively, at 24 hours compared to the c-ontrol. 
Discussion 
Naturally derived antimicrobials for food preservation may be extracted from plant, 
animal or microbial sources.  Examples of such antimicrobials are phosvitin and nisin.  
Phosvitin is a glycoprotein from egg yolk (Mecham and Olcott, 1949).  It is currently known 
for being the most phosphorylated protein in nature (Taborsky, 1983).  Also it is known to 
have a very strong chelating ability, can bind up to 60 mol of Fe
2+
 per phosvitin molecule 
(Mecham and Olcott, 1949; Taborsky, 1963; Webb et al., 1973; Albright et al., 1984).  Nisin, 
is a bacteriocin, produced by Lactococcus lactis spp. lactis. Currently it is the only 
bacteriocin approved for use in foods.  The antimicrobial spectrum of nisin is limited to some 
species of gram-positve bacteria.  It is generally ineffective against Gram-negative bacteria. 
However, when combined with chelating agents such as ethylenediametetraacetic acid 
(EDTA) enhanced bactericidal effects have been observed (Gill and Holly, 2000; Branen and 
Davidson, 2004).     
In the present study we exploited the metal chelating ability of phosvitin to enhance 
the activity of nisin.  We hypothesized that phosvitin, would destabilize the outer membrane 
of Gram-negative activity to allow nisin to penetrate the bacterial cell.  In this regard, we 
used a combination of phosvitin and nisin to inhibit growth of pathogens in a laboratory 
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broth medium and in a commercial-type soup held at abusive temperatures.  Phosvitin was 
inhibitory in a dose dependent manner against S. enterica, E. coli O157:H7 and S. aureus in a 
laboratory broth medium.  Nisin alone was ineffective against the Gram-negative bacteria, as 
expected.  Interestingly the combination of phosvitin and nisin was not effective in 
inactivating the pathogens.  In fact the antimicrobial effect of the combination was quite 
similar to the effect of phosvitin used alone.  The results of the study suggest that the 
combination of phosvitin and nisin under these circumstances would not be cost efficient, 
due to possible requirements for higher concentrations of phosvitin to achieve the desired 
antimicrobial control.  However, future studies should be conducted to determine phosvitin 
mechanism of action and test the efficacy of phosvitin peptides.  
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TABLE 1. 
a
Ingredients in dehydrated onion and mushroom soup/dip mix. 
Cornstarch  
Dehydrated onions  
Salt  
Monosodium glutamate  
Maltodextrin  
Wheat flour  
Dehydrated mushrooms  
Partially hydrogenated soybean oil  
Hydrolyzed protein (corn, soy, wheat)  
Autolyzed yeast extract  
Caramel color  
Onion powder  
Guar gum  
Garlic powder  
Natural flavors  
Disodium guanylate  
Disodium inosinate  
*Sodium 700 mg- 29% 
a
 Ingredients are listed in the same order as they appear on the label of the package 
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Figure 4. Growth of Salmonella enterica in BHI broth (35 °C) supplemented with 
various concentrations of phosvitin. 
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Figure 2. Growth of Escherichia coli O157:H7 in BHI broth (35°C) supplemented with 
various concentrations of phosvitin. 
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Figure 3. Growth of Staphylococcus aureus in BHI broth (35 °C) supplemented with 
various concentrations of phosvitin. 
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Figure 4. The effect of phosvitin combined with nisin against Salmonella enterica in BHI 
broth at 35 °C. 
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Figure 5. The effect of phosvitin combined with nisin against Escherichia coli O157:H7 
in BHI broth at 35 °C. 
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Figure 6. The effect of phosvitin combined with nisin against Staphylococcus aureus in 
BHI broth at 35 °C 
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TABLE 2.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
nisin against Salmonella enterica in onion mushroom soup held at 12 ºC for 8 days. 
 
Viable count (Log10 CFU/ml)
x 
Treatment 
 
2d 4d 6d 8d 
 
Control 4.60 ± 0.05ax 6.26 ± 2.51ax 6.02 ± 3.44ax 6.95 ± 3.62ax 
 
Phosvitin (60mg/ml) 4.42 ± 0.34ax 4.53 ± 0.14ax 4.49 ± 0.42ax 5.28 ± 1.59ax 
 
Nisin (1000 IU) 4.43 ± 0.14ax 5.08 ± 0.80ax 6.35 ± 2.93ax 6.76 ± 3.80ax 
 
Phos + Nis (1000 IU) 4.49 ± 0.55ax 4.34 ± 0.13ax 4.29 ± 0.41ax 4.35 ± 0.57ax 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Means with a different letter within a row differ significantly (P<0.05)  
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TABLE 3.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
nisin against Escherichia coli O157:H7 in onion mushroom soup held at 12 ºC for 8 
days. 
 
Viable count (Log10 CFU/ml)
x 
Treatment 
 
2d 4d 6d 8d 
 
Control 4.80  ±  0.20ax 5.66 ± 1.18ax 6.74 ± 3.37ax 6.90 ± 3.47ax 
 
Phosvitin (60mg/ml) 4.45  ±  0.74ax 4.54 ± 0.38ax 4.50 ± 0.32ax 4.62 ± 0.84ax 
 
Nisin (1000 IU) 4.09  ±  0.09ax 6.07 ± 2.29ax 6.14 ± 3.23ax 6.49 ± 3.81ax 
 
Phos + Nis (1000 IU)  4.52  ±  0.31ax 4.10 ± 0.22ax 4.16 ± 0.46ax 4.26 ± 0.21ax 
 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Means with a different letter within a row differ significantly (P<0.05) 
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TABLE 4.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
nisin against Staphylococcus aureus in onion mushroom soup held at 12 ºC for 8 days. 
 
Viable count (Log10 CFU/ml)
x 
Treatment 
 
2d 4d 6d 8d 
 
Control 5.02 ± 0.54ax 4.16 ± 0.20ay 4.29 ± 0.05axy 4.32 ± 0.25axy 
 
Phosvitin (60mg/ml) 3.76 ± 0.67bx 3.79 ± 0.44ax 3.60 ± 0.48abx 3.4 ± 0.32abx 
 
Nisin (500 IU) 2.27 ± 0.52cx 1.9 ± 0.64bcx 2.01 ± 0.31cdx 1.85 ± 0.33cdx 
 
Nisin (1000 IU) 1.83 ± 0.34cx 1.23 ± 1.06cx 1.15 ± 0.99dx 0.93 ± 0.81dx 
 
Phos + Nis (500 IU) 3.05 ± 0.27bcx 2.76 ± 0.28abcx 2.82 ± 0.52bcx 2.65 ± 0.53bcx 
 
Phos + Nis (1000 IU) 3.02 ± 0.17bcx 2.85 ± 0.20abx 2.69 ± 0.27bcx 2.48 ± 0.19bcx 
 
x
Each reported value for viable count represents the mean (standard deviation) of three independent 
replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Means with a different letter within a row differ significantly (P<0.05) 
  
 158 
 
TABLE 5.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
nisin against Salmonella enterica in a mushroom/onion soup held at 35 ºC for 24 hours. 
 
Viable count (Log10 CFU/ml)
x 
Treatment 
 
4h 8h 12h 24h 
 
Control 7.63 ± 0.31az 9.46 ± 1.29ay 10.28 ± 0.26axy 11.31 ± 0.02ax 
 
Phosvitin (60mg/ml) 5.52 ± 0.95bcz 6.95 ± 0.51byz 8.12 ± 0.50by 10.99 ± 0.03ax 
 
Nisin (1000 IU) 7.06 ± 0.28aby 10.37 ± 0.63ax 10.62 ± 0.68ax 11.07 ± 0.34ax 
 
Phos + Nis (1000 IU)  5.08 ± 0.69cz 6.80 ± 0.77by 7.38 ± 0.01by 9.15 ± 0.48bx 
 
x
Each reported value for viable count represents the mean (standard deviation) of three independent 
replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Means with a different letter within a row differ significantly (P<0.05) 
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TABLE 6.  Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
nisin against Escherichia coli O157:H7 in onion mushroom soup held at 35 ºC for 24 
hours. 
 
Viable count (Log10 CFU/ml)
x 
Treatment 
 
4h 8h 12h 24h 
 
Control 7.59 ± 0.07az 9.62 ± 0.30ay 9.99 ± 0.12ay 10.69 ± 0.27ax 
 
Phosvitin (60mg/ml) 4.54 ± 0.95by 5.29 ± 1.51by 6.12 ± 1.51by 9.23 ± 0.17bx 
 
Nisin (1000 IU) 8.15 ± 0.39ay 9.58 ± 0.88ax 10.13 ± 0.07ax 10.65 ± 0.51ax 
 
Phosvitin + Nisin  4.48 ± 0.51by 5.00 ± 0.86by 5.76 ± 0.48by 8.10  ± 0.20cx 
 
xEach reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,cMeans with a different letter within a column differ significantly (P<0.05) 
x,y,zMeans with a different letter within a row differ significantly (P<0.05) 
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TABLE 7. Antibacterial effectiveness of phosvitin (60 mg/ml) alone or combined with 
nisin against Staphylococcus aureus in onion mushroom soup held at 35 ºC for 24 hours. 
 
Viable count (Log10 CFU/ml)
* 
Treatment 
 
4h 8h 12h 24h 
 
Control 5.6 ± 0.58az 7.20 ± 0.58ay 8.28 ± 0.74axy 8.83 ± 0.25ax 
 
Phosvitin (60mg/ml) 4.38 ± 0.88abx 4.78 ± 1.22abx 5.07 ± 1.54abx 6.06 ± 1.44abx 
 
Nisin (500 IU) 3.01 ± 0.98bcy 4.13 ± 1.23bxy 4.69 ± 1.30bxy 6.75 ± 0.92abx 
 
Nisin (1000 IU) 1.97 ± 0.94cy 2.83 ± 1.20by 4.05 ± 1.27bxy 5.76 ± 0.59abx 
 
Phos + Nis (500 IU) 3.76 ± 0.82abcx 3.76 ± 0.76bx 4.05 ± 1.21bx 5.68 ± 1.19abx 
 
Phos + Nis (1000 IU) 3.46 ± 0.65abcx 3.46 ± 0.67bx 3.18 ± 0.79bx 4.52 ± 1.96bx 
 
*
Each reported value for viable count represents the mean (standard deviation) of three independent 
replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05) 
x,y,z
Means with a different letter within a row differ significantly (P<0.05) 
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THE DEATH RATE OF FOODBORNE PATHOGENIC BACTERIA EXPOSED TO 
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Abstract 
Carvacrol is a plant-derived antimicrobial compound that has strong antibacterial 
activity.  In spite of numerous published research reports on the antimicrobial effectiveness 
of carvacrol, only few have attempted to elucidate its mechanism of bactericidal action. 
Washed cells of Escherichia coli O157:H7, Listeria monocytogenes, Salmonella enterica, 
and Staphylococcus aureus were suspended to obtain ~ 1 x 10
8
 CFU/ml in 0.6% NaCl (37 
ºC) containing carvacrol at 0.0 (control), 0.2, and 0.4 mg/ml.  At 5-min intervals, suspensions 
were sterile filtered and each filtrate analyzed for material with A260.  Viability of the cell 
suspensions was evaluated by enumeration on both non-selective and selective agars.  The 
cellular death rate was determined by using absorbance and viability data.  Cell morphology 
was evaluated by transmission electron microscopy.  For all organisms, A260 increased 
significantly with increased carvacrol concentration and exposure time.  Within 0.2 min of 
exposure to carvacrol (0.4 mg/ml) initial viable numbers of E. coli O157:H7 and L. 
monocytogenes decreased by 8.90 and 6.64 Log CFU/ml, respectively.  There was a very 
strong correlation between the initial rate of release of A260 and death rate of the pathogens (r 
= 0.998).  At 0.4 mg/ml carvacrol, E. coli O157:H7 cells appeared collapsed and showed 
signs of lysis when observed by transmission electron microscopy.  At 0.4 and 0.6 mg/ml 
carvacrol, L. monocytogenes cells showed no physical damage; however, loss of intracellular 
material was observed by transmission electron microscopy.  It was concluded that carvacrol-
induced death of foodborne pathogens involves disruption of the cytoplasmic membrane. 
Introduction 
Changing consumer attitude to the use of synthetic chemicals in foods has fueled  
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current interest of food manufacturers to seek naturally derived antimicrobial for food 
applications (Ultee et al., 1998).  However, the adoption of naturally-derived antimicrobials 
by the food industry has been slow due to several issues.  The major issues include precise 
identification of active ingredients and the use of relatively high antimicrobial concentrations 
that may negatively affect sensory qualities of foods (Nychas, 2003; Roller and Board, 2003).  
The antimicrobial activity of essential oils has been associated with substituted aromatic 
molecules such as cinnamaldehyde, eugenol, and carvacrol (Moleyar and Narasimhan, 1992).   
To circumvent the issue of high concentrations plant essential oils or their 
components may be used in a manner consistent with the hurdle technology concept (Adams 
and Smid, 2003; Blaszyk and Holley, 1998).  The production of multicomponent 
antimicrobial systems for foods calls for a very good understanding of the mechanism of 
action of specific components.  This knowledge can help in focusing on potentially effective 
combinations. 
Antimicrobial effects of essential oils are believed to involve interactions with the cell 
membrane; however, the actual mechanism of inhibitory action needs to be clarified (Roller 
and Board, 2003).  Experiments on the antimicrobial activity of carvacrol revealed that it 
possesses a broad spectrum of antimicrobial activity against Gram-positive and Gram-
negative bacteria (Fenaroli, 1995). Carvacrol’s antimicrobial activity encompasses 
inactivation of fungi (Chami et al., 2005; Tampieri et al., 2005), parasites (Lindberg et al., 
2000), and insects (Panella et al., 2005).  In spite of the large amount of research on carvacrol 
performed in recent years little is understood in regard to its antibacterial mechanism of 
action.  Based on carvacrol’s hydrophobicity, the bacterial membrane seems to be a likely 
initial target of this naturally-derived antimicrobial.  Ultee et al. (1999) demonstrated that 
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carvacrol at 0.25 and 1.0 mM increased cytoplasmic membrane permeability for protons and 
potassium ions, respectively, in Bacillus cereus.  Xu et al. (2008) reported that both carvacrol 
and thymol increased the permeability of the cytoplasmic membrane of Escherichia coli.  
More recently La Storia et al. (2011), using atomic force microscopy analysis, demonstrated 
alterations in surface structure of several carvacrol-treated foodborne bacteria.  The main 
objective of the present study was to determine if the bactericidal effect of carvacrol is linked 
to cytoplasmic membrane damage in selected foodborne pathogenic bacteria. 
Materials and Methods 
Bacterial cultures and culture conditions. Salmonella enterica (Typhimurium-
ATCC 14802), Escherichia coli O157:H7 (ATCC 438952) and Listeria monocytogenes 
(Scott A - NADC-2045 – 4b) and Staphylococcus aureus (ATCC 6538) were used in the 
present study.  All cultures were obtained from the culture collection of the Microbial Food 
Safety Laboratory, Iowa State University, Ames, IA.  Stock cultures were kept frozen (-70 
ºC) in Brain Heart Infusion (BHI) broth (Difco, Becton, Dickinson, Sparks, MD) 
supplemented with 10% (vol/vol) glycerol.  Stock cultures were activated in BHI broth (pH 
7.2) and incubated at 35 °C.  At least two consecutive 18 to 22-h transfers of each stock 
culture were carried out before using the cells as inocula in each experiment. 
Chemicals.  A commercial preparation of carvacrol (Aldrich W224502) and sodium 
chloride (NaCl) was purchased from Sigma-Aldrich.   
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Preparation of treatments.  Stock solutions of carvacrol (0.20 mg/ml, 0.40 mg/ml) 
were prepared in 0.6% saline.  Each treatment (30 ml) was transferred aseptically into 
separate, sterile tubes and held at 37 °C for 30 min in a water bath prior to inoculation.    
Preparation of cell suspension.  Pathogens were grown separately in Erlenmeyer 
flasks containing 100ml of BHI at 35 °C.  After 18 h the cells were be harvested by 
centrifugation in a Beckman J2-21 centrifuge (Beckman Instruments Inc., Palo Alto Calif.) 
operating at 10,000 x g for 10 min at 4 °C.  The cell pellets were resuspended in 0.6% saline 
to give a final viable cell concentration of approximately 2.0 x 10
10
 CFU/ml as determined by 
plate counts on tryptic soy agar plus yeast extract (TSAYE).  
Exposure to treatment.  Each tube of prewarmed treatment (carvacrol) was 
inoculated with 500 µl of cell suspension to give a final concentration of 5.2 x10
8
 CFU/ml.  
Cells were mixed immediately by vortexing and then held at 37 °C.  Note that 12 s elapsed 
from the time of inoculation of the buffer to the time cells were plated or diluted in buffered 
peptone water (Difco Laboraroties, Detroit, Mich.); time zero represented approximately 12 s 
of exposure.  At time 0, 5, 10, 15 min, 5ml aliquots of treated cell suspension were removed 
from the treatment tubes.  Of the treated cell suspension 1 ml was added to 9 ml of buffered 
peptone water and vortexed, then plated onto selective and nonselective agar. 
Simultaneously, the remaining 4.0 ml of treated cell suspension was filtered through a 25mm 
diameter Luer Lock plastic syringe.  Filtrates were then examined for material with A260 (206 
nm AM). 
Measurement of cellular leakage.  Leakage of cytoplasmic contents was determined 
by the detection of 260 nm absorbing material (AM) in the cell filtrates.  Quartz cuvettes 
containing 3 ml of cell filtrate were scanned at wavelengths ranging from 400 to 230 nm at a 
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scan speed of 500 nm per min using a UV spectrophotometer (Beckman Instruments).  All 
treatments were replicated 3 times. 
Cell viability.  Cell viability was determined by serially diluting treated cells in 
buffered peptone water followed by surface plating 1.0 ml onto nonselective and selective 
agar media. TSAYE was used as the nonselective medium.  Sorbitol MacConkey agar (Difco 
Laboratories, Detroit, Mi) and modified Oxford agar (Oxoid/Unipath, Columbia, Md.) were 
used as selective media for E. coli O157:H7 and L. monocytoogenes. 
Transmission electron microscopy.  Pelletted cells were resuspended in fresh 
fixative containing 2.5% (vl/vol) glutaraldehyde in 0.1 M SCB and then held at 4 °C for 2 h. 
The cells were pelletted by centrifugation, washed three times with 0.1 M SCB, and fixed 
with 1% osmium tetroxide (OsO4) in 0.1 M SCB for 3 h at 25 °C.  After three buffer washes 
in 0.1 M SCB, the cells were negatively stained and prepared for transmission electron 
microscopy. 
Statistical analysis.  Three independent replications of each experiment were 
performed. Mean numbers of survivors E. coli O157:H7 or L. monocytogenes were 
statistically analyzed using SAS statistical software version 8.1 (SAS Institute Inc., Cary, 
N.C.).  Treatment means were evaluated for statistically significant differences using Tukey’s 
test.  Significant differences were defined at P < 0.05 for all the experimental data. 
Results 
 Effect of carvacrol on cell viability.  The viability of E. coli O157:H7 and L. 
monocytogenes decreased as time of exposure to carvacrol increased.  Viable counts of E. 
coli O157:H7 in 0.6% saline with added carvacrol (0.4 mg/ml) declined faster than those of 
 167 
 
L. monocytogenes at that same concentration of carvacrol (Fig. 1 and 2).  After 0.2 min, the 
death rate (Log10 reductions per min) of both E. coli O157:H7 and L. monocytogenes 
decreased (Fig. 1 and 2). 
 Leakage of cytoplasmic constituents.  At carvacrol concentrations of 0.2, 0.4, and 
0.8 mg/ml leakage of 260 nm absorbing material (AM) from E. coli O157:H7, L. 
monocytogenes, S. enterica, and S. aureus increased with time.  The amount of 260 nm AM 
released from those organisms also increased as carvacrol concentration increased (Table 1). 
There was a strong correlation (R
2
 = 0.9981) between leakage of 260 nm AM and death rate 
of the cells.    
 Effect of carvacrol on cell microtopography.  Cells of E. coli O157:H7 that were 
exposed to 0.4, and 0.6 mg/ml carvacrol appear wrinkled and collapsed (Fig. 4 C and D) 
whereas L. monocytogenes cells exposed to those same carvacrol concentrations retained 
their shape (Fig. 5 C and D).  Loss of intracellular material was seen in cells of E. coli 
O157:H7 (Figure 6 B and C) and L. monocytogenes exposed to 0.4 and 0.6 mg/ml carvacrol.  
 Discussion 
There is rapidly increasing trend towards the use of plant-derived antimicrobials.  One such 
antimicrobial is carvacrol, which is part of the essential oil fractions of oregano (60 to 70% 
carvacrol) and thyme (45% carvacrol).  The antimicrobial effectiveness of carvacrol has been 
previously reported (Lambert et al., 2001; Valero and Frances, 2006).  Carvacrol’s 
mechanism of antibacterial action has been purportedly associated with damage of the 
cytoplasmic membrane (Ultee et al., 1999, 2002; Ousslah et al., 2006).  While various 
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carvacrol concentrations have been reported to cause cytoplasmic membrane damage, to date 
no research has correlated the extent of carvacrol induced membrane damage (as evidenced 
by leakage of 260 nm AM) with bacterial death rate.  The rapid death of both E. coli 
O157:H7 and L. monocytogenes in 0.0.6% saline during exposure to relatively low 
concentrations of carvacrol (0.2 or 0.4 mg/ml) reflects the bactericidal characteristic of 
carvacrol.  While the viable numbers of both pathogens rapidly decreased within 0.2 min, E. 
coli O157:H7 exhibited a greater sensitivity to carvacrol compared to L. monocytogenes. E. 
coli O157:H7’s loss of viability seemed greater than that of L. monocytogenes at both 
concentrations of carvacrol tested in the present study.  La Storia et al. (2011) also reported 
that gram negative E. coli O157:H7 was less resistant to carvacrol exposure.  The phenolic 
component of carvacrol has prompted research focused on its effect on structural and 
functional damage to cellular membranes (Sikkema et al., 1995, Sivropoulou et al., 1996, 
Ultee et al., 1999).   Several methods have been used to investigate the antibacterial 
mechanism of action of carvacrol: spectrofluorometry (Ultee et al., 1999, 2002; Lambert, 
2001), scanning electron microscopy (Kwon et al., 2003; Di Pasqua et al., 2007), confocal 
laser scanning microscopy (Gill and Holly, 2006) and flow cytometry (Xu et al., 2008).  It is 
well known that the membrane damaging effects of certain disinfectants such as triclosan, 
cresol, hexachloaphene against bacteria is due to their phenolic constituents (Bean and Das, 
1966; Heath et al., 2000).  Damage to the bacterial cytoplasmic membrane can result in 
leakage of 260 nm absorbing material (AM).  In the present study the increased leakage of 
260 nm AM from cells of E. coli O157:H7, L. monocytogenes, S. enterica, and S. aureus 
during their exposure to carvacrol indicated that their cytoplasmic membranes endured 
damage and were unable to retain cytoplasmic constituents.  Damage to the cytoplasmic 
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membrane was consistent with release of 260 nm AM (Fig. 3).  The absorption spectra for 
nucleic acids have a maximum at 260 nm (Ulitzur, 1972); therefore, the 260 nm AM released 
by carvacrol-treated cells most likely consisted of purines and pyrimidines from the 
metabolic pool. 
Negative stain and transmission electron microscopy provided further evidence for 
cytoplasmic membrane damage in cells exposed to carvacrol.  Carvacrol-treated E. coli 
O157:H7 cells (as seen in transmission electron microscopy photographs) appeared wrinkled,  
collapsed, and showed loss of cellular constituents compared to control cells (Fig. 4 and Fig. 
6).  Interestingly, although carvacrol-treated L. monocytogenes cells endured damage to the 
cytoplasmic membrane no signs of wrinkled or collapsed cells were observed in the electron 
micrographs; however, loss of cellular material was observed in Fig. 7.  A plausible 
explanation for this observation is that L. monocytogenes is a Gram-positive bacterium and 
has a very thick cell wall (peptidoglycan) that better maintain the shape of the cell compared 
to Gram-negative bacteria such as E. coli.   
Based on the results of the present study, particularly the very strong correlation (R
2
 = 
0.9981) between leakage of 260 nm AM from carvacrol-treated cells and their death rate, we 
conclude that carvacrol induced death of foodborne pathogenic bacteria involves disruption 
of the cytoplasmic membrane. 
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FIGURE 1. E. coli O157:H7 survivors after exposure to carvacrol in 0.6% saline
x
. 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment. 
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FIGURE 2. L. monocytogenes survivors after exposure to carvacrol in 0.6% saline
x
. 
x
Each reported value for viable count represents the mean of three independent replications 
of the experiment. 
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TABLE 1.  Effect of varying concentration of carvacrol on DNA leakage of Escherichia 
coli O157:H7 (ATCC 43895), Listeria monocytogenes (Scott A), Salmonella enterica 
(Typhimurium) and Staphylococcus aureus (ATCC 6538) in 0.6% saline solution for 15 
minutes. 
 
260 nm AM
x 
Treatment 
 
0.2 m 5m 10m 15m 
E. coli O157:H7      
 
Control 0.04 ± 0.00a 0.04 ± 0.00b 0.04  ± 0.00b 0.04 ± 0.00b 
 
Carvacrol 0.2 mg/ml 0.13 ± 0.08a 0.19 ± 0.14ab 0.34 ± 0.21ab 0.27 ± 0.17b 
 
Carvacrol 0.4 mg/ml 0.20 ± 0.09a 0.28 ± 0.11a 0.33 ± 0.13ab 0.31 ± 0.17ab 
 
Carvacrol 0.8 mg/ml 0.17 ± 0.04a 0.23 ± 0.02ab 0.48 ± 0.12a 0.62 ± 0.12a 
L. monocytogenes     
 
Control 0.03 ± 0.00b 0.03 ± 0.00c 0.03 ± 0.00c 0.03 ± 0.00b 
 
Carvacrol 0.2 mg/ml 0.23 ± 0.03a 0.21 ± 0.11b 0.20 ± 0.09bc 0.21 ± 0.16b 
 
Carvacrol 0.4 mg/ml 0.18 ± 0.06a 0.26 ± 0.04ab 0.33 ± 0.13b 0.21 ± 0.70b 
 
Carvacrol 0.8 mg/ml 0.18 ± 0.02a 0.40 ± 0.03a 0.61 ± 0.08a 0.61 ± 0.03a 
S. enterica     
 
Control 0.04 ± 0.00a 0.04 ± 0.00b 0.04 ± 0.00b 0.04 ± 0.00c 
 
Carvacrol 0.2 mg/ml 0.23 ± 0.17a 0.25 ± 0.15ab 0.30 ± 0.22ab 0.25 ± 0.15bc 
 
Carvacrol 0.4 mg/ml 0.17 ± 0.07a 0.27 ± 0.12ab 0.38 ±0.13a 0.47 ± 0.04b 
 
Carvacrol 0.8 mg/ml 0.18 ± 0.07a 0.42 ± 0.02a 0.60 ± 0.02a 0.95 ± 0.23a 
S. aureus     
 
Control 0.05 ±0.0 0a 0.05 ± 0.00b 0.05 ± 0.00b 0.05 ± 0.00b 
 
Carvacrol 0.2 mg/ml 0.23 ± 0.10a 0.22 ± 0.13ab 0.30 ± 0.15a 0.35 ± 0.22a 
 
Carvacrol 0.4 mg/ml 0.14 ± 0.05a 0.29 ± 0.10a 0.26 ± 0.08ab 0.24 ± 0.01ab 
 
Carvacrol 0.8 mg/ml 0.20 ± 0.11a 0.20 ± 0.02ab 0.24 ± 0.05ab 0.38 ± 0.05a 
x
Each reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c
Means with a different letter within a column differ significantly (P<0.05)  
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FIGURE 3. Relationship between initial rate of leakage of 260 nm AM and death rate for 
E. coli O157:H7, exposed to 0.20 mg/ml and 0.40 mg/ml carvacrol in 0.6% saline.  
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FIGURE 4. Negative staining of Escherichia coli O157:H7 control (A) and cells exposed 
to carvacrol 0.20 mg/ml (B), 0.40 mg/ml (C), and 0.60 mg/ml (D) in 0.6% saline for 15 
min.  
  
A B 
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FIGURE 5. Negative staining of Listeria monocytogenes control (A) and cells exposed to 
carvacrol, 0.20 mg/ml (B), 0.40 mg/ml (C), and 0.60 mg/ml (D) in 0.6% saline for 15 min.  
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FIGURE 6. Transmission Electron Microsopy (TEM) of Escherichia coli O157:H7 exposed 
to carvacrol 0.0 mg/ml (control) (A), 0.4 mg/ml (B), and 0.60 mg/ml (C) in 0.6% saline for 
15 min.  
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FIGURE 7. Transmission Electron Microsopy (TEM) of Listeria monocytogenes exposed to 
carvacrol 0.0 mg/ml (control) (A), 0.4 mg/ml (B), and 0.60 mg/ml (C) in 0.6% saline for 15 
min.  
C 
B A 
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CHAPTER 7. GENERAL CONCLUSIONS 
Bacterial pathogens present in food and beverages can infect humans and cause 
foodborne illnesses.  Naturally-derived antimicrobials from plant, animal or microbial 
sources are gaining increased attention from the food industry as consumers demand more 
natural food products with no synthetic chemical preservatives.   
The present research indicated that combinations of two naturally-derived 
antimicrobials namely carvacrol (from oregano or thyme) and phosvitin (from egg yolk) are 
strongly inhibitory to Escherichia coli O157:H7, Listeria monocytogenes, Salmonella 
enterica, and Staphylococcus aureus in both laboratory broth media and in onion mushroom 
soup stored at abusive temperatures (12 and 35 ºC).  Phosvitin (60 mg/ml) combined with 
carvacrol (0.4 mg/ml) proved to be the most effective combination for controlling the 
foodborne pathogens used in the present study.  Phosvitin and carvacrol exert a bacteriostatic 
and bactericidal effect, respectively, against foodborne pathogenic bacteria.  Possible 
mechanism of antibacterial action of carvacrol is linked to cytoplasmic membrane damage.   
Phosvitin (60 mg/ml) combined with nisin (1000 IU) does not offer any greater 
antimicrobial effect than phosvitin used alone against Gram-negative foodborne pathogens in 
onion mushroom soup held at 12 °C and 35 °C.  Further research is needed to address the 
following: sensory characteristics (organoleptic properties), possible combinations with other 
hurdle techniques (antimicrobials, high pressure), and optimize combinations in various food 
products as a natural source of food safety and food preservation.   
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